{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:25:39Z","timestamp":1793057139227,"version":"4.5.0"},"reference-count":559,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008741","name":"EULAR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008741","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.clim.2019.04.009","type":"journal-article","created":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T05:45:18Z","timestamp":1556516718000},"page":"81-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":186,"special_numbering":"C","title":["Sjogren\u2019s syndrome: An update on disease pathogenesis, clinical manifestations and treatment"],"prefix":"10.1016","volume":"203","author":[{"given":"Frederick B.","family":"Vivino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vatinee Y.","family":"Bunya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomina","family":"Massaro-Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chadwick R.","family":"Johr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie L.","family":"Giattino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie","family":"Schorpion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Shafer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammon","family":"Peck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Sivils","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Chiorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Julian L.","family":"Ambrus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2019.04.009_bb0005","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.47","article-title":"Sjogren syndrome","volume":"2","author":"Brito-Zeron","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.clim.2019.04.009_bb0010","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1600-0722.2004.00183.x","article-title":"Sjogren's syndrome","volume":"113","author":"Delaleu","year":"2005","journal-title":"Eur J Oral Sci"},{"issue":"9","key":"10.1016\/j.clim.2019.04.009_bb0015","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev-pathol-012513-104728","article-title":"Sjogren's syndrome","volume":"9","author":"Mavragani","year":"2014","journal-title":"Ann Rev of Pathol"},{"key":"10.1016\/j.clim.2019.04.009_bb0020","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","article-title":"Sjogren's syndrome","volume":"366","author":"Fox","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.clim.2019.04.009_bb0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/art.23177","article-title":"Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I","volume":"58","author":"Helmick","year":"2008","journal-title":"Arthritis Rheumatism"},{"key":"10.1016\/j.clim.2019.04.009_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coms.2013.09.002","article-title":"Sjogren's syndrome an update on epidemiology and current insights on pathophysiology","volume":"26","author":"Reksten","year":"2014","journal-title":"Oral Maxillofacial Surgery Clin North Am"},{"key":"10.1016\/j.clim.2019.04.009_bb0035","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/rheumatology\/37.10.1069","article-title":"Sjogren's syndrome: a community-based study of prevalence and impact","volume":"37","author":"Thomas","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb0040","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1136\/annrheumdis-2014-205375","article-title":"Epidemiology of primary Sjogren's syndrome: a systematic review and meta-analysis","volume":"74","author":"Qin","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clim.2019.04.009_bb0045","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1080\/03009740802001426","article-title":"Primary Sjogren's syndrome in men","volume":"37","author":"Gondran","year":"2008","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb0050","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s12325-017-0501-3","article-title":"The potential role for early biomarker testing as part of a modern, multidisciplinary approach to Sjogren's syndrome diagnosis","volume":"34","author":"Beckman","year":"2017","journal-title":"Adv Ther"},{"key":"10.1016\/j.clim.2019.04.009_bb0055","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10787-998-0012-6","article-title":"Sjogren's syndrome: history, clinical and pathological features","volume":"6","author":"Parke","year":"1998","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.clim.2019.04.009_bb0060","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1755-3768.1951.tb07613.x","article-title":"Some problems concerning keratoconjunctivitis sicca and the sicca-syndrome","volume":"29","author":"Sjogren","year":"1951","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"10.1016\/j.clim.2019.04.009_bb0065","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00005792-196505000-00001","article-title":"Sjoegren's syndrome. a clinical, pathological, and serological study of sixty-two cases","volume":"44","author":"Bloch","year":"1965","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clim.2019.04.009_bb0070","first-page":"199","article-title":"The spectrum of benign to malignant lymphoproliferation in Sjogren's syndrome","volume":"10","author":"Anderson","year":"1972","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb0075","first-page":"1046","article-title":"Advances in the diagnosis and concept of Sjogren's syndrome (autoimmune exocrinopathy)","volume":"30","author":"Strand","year":"1979","journal-title":"Bull Rheum Dis"},{"key":"10.1016\/j.clim.2019.04.009_bb0080","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1600-0714.1977.tb01651.x","article-title":"Immunopathology of Sjogren-like disease in NZB\/HZW mice","volume":"6","author":"Keyes","year":"1977","journal-title":"J Oral Pathol"},{"key":"10.1016\/j.clim.2019.04.009_bb0085","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.4049\/jimmunol.135.3.1707","article-title":"Association between the Ro and La antigenic determinants: immunodiffusion analysis of human spleen extract","volume":"135","author":"Eisenberg","year":"1985","journal-title":"J Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb0090","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1177\/00220345870660S214","article-title":"Systemic therapy of salivary gland hypofunction","volume":"66","author":"Fox","year":"1987","journal-title":"J Dental Res"},{"key":"10.1016\/j.clim.2019.04.009_bb0095","first-page":"737","article-title":"Immunopathogenesis of Sjogren's syndrome","volume":"24","author":"Moutsopoulos","year":"1988","journal-title":"Isr J Med Sci"},{"key":"10.1016\/j.clim.2019.04.009_bb0100","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.3458307","article-title":"Gene interaction at HLA-DQ enhances autoantibody production in primary Sjogren's syndrome","volume":"232","author":"Harley","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.clim.2019.04.009_bb0105","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1177\/0022034510380414","article-title":"Comparative human salivary and plasma proteomes","volume":"89","author":"Loo","year":"2010","journal-title":"J Dental Res"},{"key":"10.1016\/j.clim.2019.04.009_bb0110","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cden.2004.10.002","article-title":"Salivary hypofunction and xerostomia: diagnosis and treatment","volume":"49","author":"Atkinson","year":"2005","journal-title":"Dent Clin North Am"},{"key":"10.1016\/j.clim.2019.04.009_bb0115","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/154405910808700411","article-title":"Oral manifestations of Sjogren's syndrome","volume":"87","author":"Mathews","year":"2008","journal-title":"J Den Res"},{"key":"10.1016\/j.clim.2019.04.009_bb0120","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejim.2016.01.014","article-title":"Increased risk of concurrent gastroesophageal reflux disease among patients with Sjogren's syndrome: A nationwide population-based study","volume":"31","author":"Chang","year":"2016","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.clim.2019.04.009_bb0125","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/000163501750266684","article-title":"Dental caries and dental health behavior of patients with primary Sjogren syndrome","volume":"59","author":"Christensen","year":"2001","journal-title":"Acta Odontol Scand"},{"key":"10.1016\/j.clim.2019.04.009_bb0130","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1472-6890-5-4","article-title":"Salivary changes and dental caries as potential oral markers of autoimmune salivary gland dysfunction in primary Sjogren's syndrome","volume":"5","author":"Pedersen","year":"2005","journal-title":"BMC Clin Pathol"},{"key":"10.1016\/j.clim.2019.04.009_bb0135","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/ncprheum0165","article-title":"The management of Sjogren's syndrome","volume":"2","author":"Mavragani","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000713","article-title":"Characterization of the oral fungal microbiome (mycobiome) in healthy individuals","volume":"6","author":"Ghannoum","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.clim.2019.04.009_bb0145","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.3899\/jrheum.100819","article-title":"Multiple oral Candida infections in patients with Sjogren's syndrome -- prevalence and clinical and drug susceptibility profiles","volume":"38","author":"Yan","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb0150","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jtos.2014.12.001","article-title":"Clinical guidelines for management of dry eye associated with Sjogren disease","volume":"13","author":"Foulks","year":"2015","journal-title":"Ocular Surface"},{"key":"10.1016\/j.clim.2019.04.009_bb0155","first-page":"379","article-title":"Corneal melt as the initial presentation of primary Sjogren's syndrome","volume":"28","author":"Vivino","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb0160","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0002-9394(87)90223-6","article-title":"Chronic anterior and posterior uveitis and primary Sjogren's syndrome","volume":"104","author":"Rosenbaum","year":"1987","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clim.2019.04.009_bb0165","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3341\/kjo.2011.25.4.275","article-title":"A case of necrotizing keratoscleritis in primary Sjogren's syndrome","volume":"25","author":"Choi","year":"2011","journal-title":"Korean J Ophthalmol"},{"key":"10.1016\/j.clim.2019.04.009_bb0170","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005194","article-title":"Optic neuritis as an initial presentation of primary Sjogren syndrome: A case report and literature review","volume":"95","author":"Sun","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clim.2019.04.009_bb0175","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3899\/jrheum.160978","article-title":"Pediatric neuromyelitis optica spectrum disorder and Sjogren syndrome: more common than previously thought?","volume":"44","author":"Gmuca","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb0180","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jtos.2014.12.001","article-title":"Clinical guidlines for management of dry eye associated with Sjogren disease","volume":"13","author":"Pflugfelder","year":"2015","journal-title":"Ocul Surf"},{"key":"10.1016\/j.clim.2019.04.009_bb0185","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jtos.2016.03.003","article-title":"Ocular surface membrane-associated mucins","volume":"14","author":"Ablamowicz","year":"2016","journal-title":"Ocul Surf"},{"key":"10.1016\/j.clim.2019.04.009_bb0190","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/S0161-6420(98)98033-2","article-title":"Meibomian gland dysfunction in patients with Sjogren syndrome","volume":"105","author":"Shimazaki","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clim.2019.04.009_bb0195","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.ophtha.2017.07.010","article-title":"The pathophysiology of dry eye disease: what we know and future directions for research","volume":"124","author":"Pflugfelder","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clim.2019.04.009_bb0200","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","article-title":"TFOS DEWS II pathophysiology report","volume":"15","author":"Bron","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.clim.2019.04.009_bb0205","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1477-7525-7-46","article-title":"Primary Sjogren's Syndrome: health experiences and predictors of health quality among patients in the United States","volume":"7","author":"Segal","year":"2009","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.clim.2019.04.009_bb0210","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jtos.2018.11.003","article-title":"The impact of dry eye disease treatment on patient satisfaction and quality of life: A review","volume":"17","author":"Gomes","year":"2019","journal-title":"Ocul Surf"},{"key":"10.1016\/j.clim.2019.04.009_bb0215","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00130832-200410000-00014","article-title":"Ocular allergy and dry eye syndrome","volume":"4","author":"Bielory","year":"2004","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb0220","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.exer.2008.03.002","article-title":"Alterations in corneal sensitivity and nerve morphology in patients with primary Sjogren's syndrome","volume":"86","author":"Tuisku","year":"2008","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.clim.2019.04.009_bb0225","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/08820538.2015.1114853","article-title":"Understanding neuropathic corneal pain--gaps and current therapeutic approaches","volume":"31","author":"Goyal","year":"2016","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.clim.2019.04.009_bb0230","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ophtha.2016.11.008","article-title":"Predictors of discordance between symptoms and signs in dry eye disease","volume":"124","author":"Vehof","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clim.2019.04.009_bb0235","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/archophthalmol.2008.601","article-title":"Sterile corneal melt after descemet stripping endothelial keratoplasty in patients with previously undiagnosed Sjogren syndrome","volume":"127","author":"Shan","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clim.2019.04.009_bb0240","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1001\/archopht.125.8.1131","article-title":"Corneal perforation after conductive keratoplasty in a patient with previously undiagnosed Sjogren syndrome","volume":"125","author":"Ou","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clim.2019.04.009_bb0245","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-225428","article-title":"Corneal perforation in undiagnosed Sjogren's syndrome following topical NSAID and steroid drops post routine cataract extraction","author":"Murtagh","year":"2018","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.clim.2019.04.009_bb0250","first-page":"149","article-title":"Therapeutic contact lens-related bilateral fungal keratitis","volume":"28","author":"Hoflin-Lima","year":"2002","journal-title":"CLAO J"},{"key":"10.1016\/j.clim.2019.04.009_bb0255","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1590\/0004-282X20140097","article-title":"Sjogren syndrome and neuromyelitis optica spectrum disorder co-exist in a common autoimmune milieu","volume":"72","author":"Carvalho","year":"2014","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.clim.2019.04.009_bb0260","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/archopht.1988.01060140207023","article-title":"The optic neuritis treatment trial","volume":"106","author":"Beck","year":"1988","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clim.2019.04.009_bb0265","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1093\/rheumatology\/keu522","article-title":"The impact of primary Sjogren's syndrome on female sexual function","volume":"54","author":"van Nimwegen","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.clim.2019.04.009_bb0270","doi-asserted-by":"crossref","first-page":"R167","DOI":"10.1186\/ar3487","article-title":"A five-year prospective study of fatigue in primary Sjogren's syndrome","volume":"13","author":"Haldorsen","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.clim.2019.04.009_bb0275","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1136\/ard.59.11.875","article-title":"Fatigue in primary Sjogren's syndrome: is there a link with the fibromyalgia syndrome?","volume":"59","author":"Giles","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clim.2019.04.009_bb0280","first-page":"6","article-title":"Living with Sjogren\u2019s: summary of major findings","volume":"12","author":"Foundation, S. s","year":"2017","journal-title":"Sjogren\u2019s Quarterly"},{"key":"10.1016\/j.clim.2019.04.009_bb0285","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/rheumatology\/keq023","article-title":"Sleepiness or fatigue? Can we detect treatable causes of tiredness in primary Sjogren's syndrome?","volume":"49","author":"Theander","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.clim.2019.04.009_bb0290","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/acr.22720","article-title":"Fatigue in primary Sjogren's syndrome: clinical, laboratory, psychometric, and biologic associations","volume":"68","author":"Karageorgas","year":"2016","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.clim.2019.04.009_bb0295","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1136\/ard.2007.083865","article-title":"Reduction of fatigue in Sjogren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study","volume":"67","author":"Dass","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clim.2019.04.009_bb0300","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/acr.22968","article-title":"Treatment guidelines for rheumatologic manifestations of Sjogren's syndrome: use of biologic agents, management of fatigue, and inflammatory musculoskeletal pain","volume":"69","author":"Carsons","year":"2017","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.clim.2019.04.009_bb0305","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1093\/rheumatology\/kex375","article-title":"The British Society for Rheumatology guideline for the management of adults with primary Sjogren's Syndrome","volume":"56","author":"Price","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.clim.2019.04.009_bb0310","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0049-0172(00)80016-5","article-title":"Clinical evolution, and morbidity and mortality of primary Sjogren's syndrome","volume":"29","author":"Skopouli","year":"2000","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.clim.2019.04.009_bb0315","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00005792-200207000-00003","article-title":"Primary Sjogren syndrome - Clinical and immunologic disease patterns in a cohort of 400 patients","volume":"81","author":"GarciaCarrasco","year":"2002","journal-title":"Medicine"},{"key":"10.1016\/j.clim.2019.04.009_bb0320","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000667","article-title":"Primary Sjogren syndrome in Han Chinese clinical and immunological characteristics of 483 patients","volume":"94","author":"Zhao","year":"2015","journal-title":"Medicine"},{"key":"10.1016\/j.clim.2019.04.009_bb0325","first-page":"3252","article-title":"Clinical and prognostic characteristics of 573 cases of primary Sjogren's syndrome","volume":"123","author":"Lin","year":"2010","journal-title":"Chin Med J"},{"key":"10.1016\/j.clim.2019.04.009_bb0330","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MD.0b013e318181e6af","article-title":"Primary Sjogren syndrome in Spain: clinical and immunologic expression in 1010 patients","volume":"87","author":"Ramos-Casals","year":"2008","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clim.2019.04.009_bb0335","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/rheumatology\/keq047","article-title":"Articular manifestations in primary Sjogren's syndrome: clinical significance and prognosis of 188 patients","volume":"49","author":"Fauchais","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.clim.2019.04.009_bb0340","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/acr.21610","article-title":"Primary Sjogren's syndrome as a systemic disease: a study of participants enrolled in an international Sjogren's syndrome registry","volume":"64","author":"Malladi","year":"2012","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.clim.2019.04.009_bb0345","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/MD.0b013e3181b76ab5","article-title":"Hematologic manifestations and predictors of lymphoma development in primary Sjogren syndrome: clinical and pathophysiologic aspects","volume":"88","author":"Baimpa","year":"2009","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clim.2019.04.009_bb0350","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.autrev.2018.06.015","article-title":"Arthritis in primary Sjogren's syndrome: Characteristics, outcome and treatment from French multicenter retrospective study","volume":"18","author":"Mirouse","year":"2019","journal-title":"Autoimmunity Rev."},{"key":"10.1016\/j.clim.2019.04.009_bb0355","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2015-000066","article-title":"ACPA-positive primary Sjogren's syndrome: true primary or rheumatoid arthritis-associated Sjogren's syndrome?","volume":"1","author":"Payet","year":"2015","journal-title":"RMD Open"},{"key":"10.1016\/j.clim.2019.04.009_bb0360","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1297-319X(01)00341-4","article-title":"Fibromyalgia in Italian patients with primary Sjogren's syndrome","volume":"69","author":"Ostuni","year":"2002","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.clim.2019.04.009_bb0365","first-page":"S28","article-title":"Fibromyalgia prevalence and associated factors in primary Sjogren's syndrome patients in a large cohort from the Spanish Society of Rheumatology registry (SJOGRENSER)","volume":"35","author":"Torrente-Segarra","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb0370","first-page":"S9","article-title":"Prevalence and clinical impact of fibromyalgia in patients with primary Sjogren's syndrome","volume":"34","author":"Choi","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb0375","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.autrev.2016.12.006","article-title":"Sjogren's syndrome-associated myositis with germinal centre-like structures","volume":"16","author":"Espitia-Thibault","year":"2017","journal-title":"Autoimmunity Rev"},{"key":"10.1016\/j.clim.2019.04.009_bb0380","first-page":"457","article-title":"Myositis in primary Sjogren's syndrome: data from a multicentre cohort","volume":"33","author":"Colafrancesco","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb0385","first-page":"55","article-title":"Hematological changes as the initial manifestation of Sjogren\u2019s syndrome","volume":"25","author":"Martinez","year":"2018","journal-title":"Rev Colomb Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb0390","first-page":"130","article-title":"Primary Sjogren's syndrome and autoimmune cytopenias: a relation often overlooked","volume":"70","author":"Khattri","year":"2012","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"10.1016\/j.clim.2019.04.009_bb0395","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00005792-200207000-00004","article-title":"Primary Sjogren syndrome - Hematologic patterns of disease expression","volume":"81","author":"RamosCasals","year":"2002","journal-title":"Medicine"},{"key":"10.1016\/j.clim.2019.04.009_bb0400","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/01.md.0000157398.37679.47","article-title":"Circulating monoclonal immunoglobulins in Sjogren syndrome - Prevalence and clinical significance in 237 patients","volume":"84","author":"BritoZeron","year":"2005","journal-title":"Medicine"},{"key":"10.1016\/j.clim.2019.04.009_bb0405","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/art.1780390508","article-title":"Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjogren's syndrome","volume":"39","author":"Tzioufas","year":"1996","journal-title":"Arthritis and rheumatism"},{"key":"10.1016\/j.clim.2019.04.009_bb0410","first-page":"438","article-title":"Hematologic manifestations of primary Sjogren's syndrome","volume":"24","author":"Manganelli","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb0415","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/rheumatology\/ket349","article-title":"Systemic involvement in primary Sjogren's syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry)","volume":"53","author":"Ramos-Casals","year":"2014","journal-title":"Rheumatology"},{"key":"10.1016\/j.clim.2019.04.009_bb0420","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.semarthrit.2008.01.014","article-title":"Prevalence and clinical relevance of autoimmune neutropenia in patients with primary Sjogren's syndrome","volume":"38","author":"Brito-Zeron","year":"2009","journal-title":"Semin Arthritis Rheumatism"},{"key":"10.1016\/j.clim.2019.04.009_bb0425","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1007\/s10067-018-4312-y","article-title":"Severe thrombocytopenia in connective tissue diseases: a single-center review of 131 cases","volume":"37","author":"Zhang","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb0430","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/acr.23264","article-title":"Natural history and predictors of progression to Sjogren's syndrome among participants of the Sjogren's international collaborative clinical alliance registry","volume":"70","author":"Shiboski","year":"2018","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.clim.2019.04.009_bb0435","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0049-0172(98)80037-1","article-title":"Cryoglobulinemia in primary Sjogren's syndrome: prevalence and clinical characteristics in a series of 115 patients","volume":"28","author":"Ramos-Casals","year":"1998","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.clim.2019.04.009_bb0440","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1002\/art.38100","article-title":"Clinically significant renal involvement in primary Sjogren's syndrome: clinical presentation and outcome","volume":"65","author":"Goules","year":"2013","journal-title":"Arthritis Rheumatism"},{"key":"10.1016\/j.clim.2019.04.009_bb0445","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1191\/0961203304lu1006oa","article-title":"Antiphospholipid antibodies in primary Sjogren's syndrome: prevalence and clinical significance in a series of 74 patients","volume":"13","author":"Fauchais","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.clim.2019.04.009_bb0450","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/bjh.13192","article-title":"Sjogren syndrome-associated lymphomas: an update on pathogenesis and management","volume":"168","author":"Nocturne","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clim.2019.04.009_bb0455","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1001\/archinte.165.20.2337","article-title":"The risk of lymphoma development in autoimmune diseases: a meta-analysis","volume":"165","author":"Zintzaras","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clim.2019.04.009_bb0460","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/ard.2005.041186","article-title":"Lymphoma and other malignancies in primary Sjogren's syndrome: a cohort study on cancer incidence and lymphoma predictors","volume":"65","author":"Theander","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clim.2019.04.009_bb0465","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/art.39518","article-title":"Rheumatoid factor and disease activity are independent predictors of lymphoma in primary Sjogren's syndrome","volume":"68","author":"Nocturne","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb0470","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1093\/annonc\/mdu365","article-title":"Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study","volume":"25","author":"Fallah","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clim.2019.04.009_bb0475","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/jnci\/djj004","article-title":"Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype","volume":"98","author":"Smedby","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clim.2019.04.009_bb0480","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1136\/annrheumdis-2011-200402","article-title":"Incidence of cancer in a nationwide population cohort of 7852 patients with primary Sjogren's syndrome in Taiwan","volume":"71","author":"Weng","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clim.2019.04.009_bb0485","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/acr.21887","article-title":"Risk of non-Hodgkin's lymphoma in primary Sjogren's syndrome: a population-based study","volume":"65","author":"Johnsen","year":"2013","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.clim.2019.04.009_bb0490","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00296-014-3051-x","article-title":"Identification of lymphoma predictors in patients with primary Sjogren's syndrome: a systematic literature review and meta-analysis","volume":"35","author":"Nishishinya","year":"2015","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.clim.2019.04.009_bb0495","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMcp1702514","article-title":"Primary Sjogren's syndrome","volume":"378","author":"Mariette","year":"2018","journal-title":"New Eng J Med"},{"key":"10.1016\/j.clim.2019.04.009_bb0500","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/art.10221","article-title":"Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren's syndrome","volume":"46","author":"Ioannidis","year":"2002","journal-title":"Arthritis Rheumatism"},{"key":"10.1016\/j.clim.2019.04.009_bb0505","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00004728-200307000-00011","article-title":"Clinical and imaging findings of lymphoma in patients with Sjogren syndrome","volume":"27","author":"Tonami","year":"2003","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.clim.2019.04.009_bb0510","series-title":"The Digestive Involvment in Systemic Autoimmune Diseases","first-page":"271","article-title":"Digestive Involvement in primary Sjogren\u2019s syndrome","author":"Retamozo","year":"2017"},{"key":"10.1016\/j.clim.2019.04.009_bb0515","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1080\/03009740701607638","article-title":"Dysphagia and dysmotility of the pharynx and oesophagus in patients with primary Sjogren's syndrome","volume":"36","author":"Mandl","year":"2007","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb0520","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.rdc.2017.09.010","article-title":"Gastrointestinal and hepatic disease in Sjogren syndrome","volume":"44","author":"Popov","year":"2018","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.clim.2019.04.009_bb0525","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0889-857X(21)00320-3","article-title":"Pulmonary and gastrointestinal manifestations of Sjogren's syndrome","volume":"18","author":"Constantopoulos","year":"1992","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.clim.2019.04.009_bb0530","first-page":"63","article-title":"Abnormal esophageal motility in primary Sjogren's syndrome","volume":"3","author":"Ramirez-Mata","year":"1976","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb0535","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/ard.44.9.610","article-title":"Oesophageal dysfunction in patients with primary Sjogren's syndrome","volume":"44","author":"Tsianos","year":"1985","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clim.2019.04.009_bb0540","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF01318111","article-title":"Esophageal function, radiography, and dysphagia in Sjogren's syndrome","volume":"31","author":"Kjellen","year":"1986","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clim.2019.04.009_bb0545","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejim.2016.01.014","article-title":"Increased risk of concurrent gastroesophageal reflux disease among patients with Sjogren's syndrome: A nationwide population-based study","volume":"31","author":"Chang","year":"2016","journal-title":"Eur J Int Med"},{"key":"10.1016\/j.clim.2019.04.009_bb0550","first-page":"834","article-title":"Autoimmune hepatitis in Tunisia. Retrospective multicenter study of 83 cases","volume":"88","author":"Debbeche","year":"2010","journal-title":"Tunis Med"},{"key":"10.1016\/j.clim.2019.04.009_bb0555","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0167-0115(88)90011-0","article-title":"Epidermal growth factor (EGF) inhibits both intrinsic factor secretion and acid secretion in histamine-stimulated isolated gastric glands","volume":"21","author":"Rackoff","year":"1988","journal-title":"Regul Pept"},{"key":"10.1016\/j.clim.2019.04.009_bb0560","first-page":"9","article-title":"The gastrointestinal manifestations of Sjogren's syndrome","volume":"90","author":"Sheikh","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clim.2019.04.009_bb0565","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/art.1780280406","article-title":"Atrophic gastritis in Sjogren's syndrome. Morphologic, biochemical, and immunologic findings","volume":"28","author":"Maury","year":"1985","journal-title":"Arthritis Rheumatism"},{"key":"10.1016\/j.clim.2019.04.009_bb0570","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/ard.50.2.97","article-title":"Types of atrophic gastritis in patients with primary Sjogren's syndrome","volume":"50","author":"Pokorny","year":"1991","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clim.2019.04.009_bb0575","first-page":"930","article-title":"Gastric biopsy in patients with Sjogren's syndrome","volume":"16","author":"Jebavy","year":"1961","journal-title":"Z Gesamte Inn Med"},{"key":"10.1016\/j.clim.2019.04.009_bb0580","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/gut.7.4.351","article-title":"Gastric studies in sjogren's syndrome","volume":"7","author":"Buchanan","year":"1966","journal-title":"Gut"},{"key":"10.1016\/j.clim.2019.04.009_bb0585","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/art.1780250905","article-title":"Serum pepsinogen I in rheumatic diseases: Reduced levels in Sjogren's syndrome","volume":"25","author":"Maury","year":"1982","journal-title":"Arthritis Rheumatism"},{"key":"10.1016\/j.clim.2019.04.009_bb0590","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/art.1780261004","article-title":"Lymphocyte infiltrations of the gastric mucosa in Sjogren's syndrome: An immunoperoxidase study using monoclonal antibodies in the avidin-biotin-peroxidase method","volume":"26","author":"Kilpi","year":"1983","journal-title":"Arthritis Rheumatism"},{"key":"10.1016\/j.clim.2019.04.009_bb0595","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/jcp.48.3.250","article-title":"Improvement of gastric inflammation and resolution of epithelial damage one year after eradication of Helicobacter pylori","volume":"48","author":"Witteman","year":"1995","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.clim.2019.04.009_bb0600","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1601-0825.2011.01796.x","article-title":"Helicobacter pylori and autoimmune diseases","volume":"17","author":"Hasni","year":"2011","journal-title":"Oral Diseases"},{"key":"10.1016\/j.clim.2019.04.009_bb0605","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.3899\/jrheum.100280","article-title":"Impaired gastric emptying in primary Sjogren's syndrome","volume":"37","author":"Hammar","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb0610","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/art.39044","article-title":"Predominant glandular cholinergic dysautonomia in patients with primary Sjogren's syndrome","volume":"67","author":"Imrich","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb0615","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.molimm.2013.06.004","article-title":"The inhibitory effects of antimuscarinic autoantibodies in the sera of primary Sjogren syndrome patients on the gastrointestinal motility","volume":"56","author":"Park","year":"2013","journal-title":"Mol Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb0620","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/MCG.0b013e3182329d9c","article-title":"Gastrointestinal and hepatic manifestations of Sjogren syndrome","volume":"46","author":"Ebert","year":"2012","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.clim.2019.04.009_bb0625","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s00296-003-0360-x","article-title":"Coeliac disease in Sjogren's syndrome--a study of 111 Hungarian patients","volume":"24","author":"Szodoray","year":"2004","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.clim.2019.04.009_bb0630","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1572-0241.1999.01011.x","article-title":"Celiac disease and markers of celiac disease latency in patients with primary Sjogren's syndrome","volume":"94","author":"Iltanen","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clim.2019.04.009_bb0635","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/ard.2004.029066","article-title":"Development of additional autoimmune diseases in a population of patients with primary Sjogren's syndrome","volume":"64","author":"Lazarus","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clim.2019.04.009_bb0640","first-page":"4","article-title":"Gastrointestinal disease in Sjogren's syndrome: related to food hypersensitivities","author":"Kim-Lee","year":"2015","journal-title":"Springerplus"},{"key":"10.1016\/j.clim.2019.04.009_bb0645","first-page":"67","article-title":"Sjogren's syndrome and Crohn's disease","volume":"3","author":"Gainey","year":"1985","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb0650","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.crohns.2009.03.005","article-title":"Sjogren's syndrome in a patient with ulcerative colitis and primary sclerosing cholangitis: Case report and review of the literature","volume":"3","author":"Katsanos","year":"2009","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.clim.2019.04.009_bb0655","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12941-014-0049-x","article-title":"Rifaximin for small intestinal bacterial overgrowth in patients without irritable bowel syndrome","volume":"13","author":"Boltin","year":"2014","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.clim.2019.04.009_bb0660","series-title":"Tips for Managing Gastrointestinal Symptoms","author":"Cateron","year":"2016"},{"key":"10.1016\/j.clim.2019.04.009_bb0665","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0248-8663(00)80098-3","article-title":"Lymphocytic colitis and Gougerot-Sjogren syndrome. Report of two cases","volume":"20","author":"Jean","year":"1999","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.clim.2019.04.009_bb0670","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s11926-011-0207-5","article-title":"Vasculitis in Sjogren's Syndrome","volume":"13","author":"Scofield","year":"2011","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.clim.2019.04.009_bb0675","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/03009740701340222","article-title":"Bowel symptoms in patients with primary Sjogren's syndrome","volume":"36","author":"Krogh","year":"2007","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb0680","first-page":"19","article-title":"Severe intestinal dysbiosis is prevalent in primary Sjogren's syndrome and is associated with systemic disease activity","author":"Mandl","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.clim.2019.04.009_bb0685","doi-asserted-by":"crossref","first-page":"498","DOI":"10.7326\/0003-4819-61-3-498","article-title":"Studies of pancreatic function in Sjoegren's syndrome","volume":"61","author":"Fenster","year":"1964","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clim.2019.04.009_bb0690","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000201622","article-title":"Pancreatic function in Sjogren's syndrome","volume":"108","author":"Hradsky","year":"1967","journal-title":"Gastroenterologia"},{"key":"10.1016\/j.clim.2019.04.009_bb0695","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF02032170","article-title":"A controlled study of the exocrine pancreatic function in Sjogren's syndrome and rheumatoid arthritis","volume":"2","author":"Gobelet","year":"1983","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb0700","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1001\/archinte.1989.00390040066013","article-title":"Exocrine pancreatic function in Sjogren's syndrome","volume":"149","author":"Coll","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clim.2019.04.009_bb0705","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000084494","article-title":"A case of autoimmune pancreatitis associated with sclerosing cholangitis, retroperitoneal fibrosis and Sjogren's syndrome","volume":"5","author":"Fukui","year":"2005","journal-title":"Pancreatology"},{"key":"10.1016\/j.clim.2019.04.009_bb0710","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/0002-9610(84)90212-5","article-title":"Sclerosing cholangitis, chronic pancreatitis, and Sjogren's syndrome: a syndrome complex","volume":"147","author":"Montefusco","year":"1984","journal-title":"Am J Surg"},{"key":"10.1016\/j.clim.2019.04.009_bb0715","first-page":"139","article-title":"Sjogren's syndrome with chronic pancreatitis, sclerosing cholangitis, and pulmonary infiltrations","volume":"92","author":"Nieminen","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clim.2019.04.009_bb0720","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.gie.2007.08.007","article-title":"Autoimmune pancreatitis: time for a collective effort","volume":"66","author":"Greenberger","year":"2007","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.clim.2019.04.009_bb0725","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1067\/mge.2003.40","article-title":"Triad of sclerosing cholangitis, chronic pancreatitis, and Sjogren's syndrome: Case report and review","volume":"57","author":"Kulling","year":"2003","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.clim.2019.04.009_bb0730","unstructured":"Moutsopoulos, H. M., G. Fragoulis, and J. H. Stone. 2018. Overview of IgG4-related disease. Up to Date. P. Roman, Waltham, MA."},{"key":"10.1016\/j.clim.2019.04.009_bb0735","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1046\/j.1365-3083.2002.01165.x","article-title":"Do autoantibodies predict autoimmune liver disease in primary Sjogren's syndrome? Data of 180 patients upon a 5 year follow-up","volume":"56","author":"Csepregi","year":"2002","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb0740","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/ard.2002.001826","article-title":"Hepatic manifestations of autoimmune rheumatic diseases","volume":"63","author":"Abraham","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clim.2019.04.009_bb0745","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/01.md.0000157397.30055.c9","article-title":"Sjogren syndrome associated with hepatitis C virus - A multicenter analysis of 137 cases","volume":"84","author":"RamosCasals","year":"2005","journal-title":"Medicine"},{"key":"10.1016\/j.clim.2019.04.009_bb0750","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1665-2681(19)31920-9","article-title":"Abnormal hepatic biochemistries and clinical liver disease in patients with primary Sjogren's syndrome","volume":"6","author":"Montano-Loza","year":"2007","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.clim.2019.04.009_bb0755","series-title":"Hepatitis C: Why People Born from 1945-65 Should Get Tested","author":"CDC","year":"2016"},{"key":"10.1016\/j.clim.2019.04.009_bb0760","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.3899\/jrheum.080874","article-title":"Systemic autoimmune diseases in patients with hepatitis C virus infection: characterization of 1020 cases (The HISPAMEC Registry)","volume":"36","author":"Ramos-Casals","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb0765","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0140-6736(92)91645-O","article-title":"Lymphocytic sialadenitis of Sjogren's syndrome associated with chronic hepatitis C virus liver disease","volume":"339","author":"Haddad","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.clim.2019.04.009_bb0770","series-title":"Pathogenesis of Primary Biliary Cholangitis (primary bliiary cirrhosis)","author":"Gershwin","year":"2018"},{"key":"10.1016\/j.clim.2019.04.009_bb0775","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.rdc.2017.09.008","article-title":"Rheumatic manifestations in autoimmune liver disease","volume":"44","author":"Selmi","year":"2018","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.clim.2019.04.009_bb0780","series-title":"Clinical Manifestations, Diagnosis and Prognosis of Primary Biliary Cholangitis (primary biliary cirrhosis)","author":"Poupon","year":"2018"},{"key":"10.1016\/j.clim.2019.04.009_bb0785","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jaut.2011.11.005","article-title":"Primary biliary cirrhosis and Sjogren's syndrome: autoimmune epithelitis","volume":"39","author":"Selmi","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.clim.2019.04.009_bb0790","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10067-005-0059-3","article-title":"Circulating auto-antibodies against nuclear and non-nuclear antigens in primary Sjogren's syndrome: prevalence and clinical significance in 335 patients","volume":"25","author":"Nardi","year":"2006","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb0795","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.3748\/wjg.v19.i31.5131","article-title":"Connective tissue diseases in primary biliary cirrhosis: a population-based cohort study","volume":"19","author":"Wang","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clim.2019.04.009_bb0800","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.20907","article-title":"Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients","volume":"42","author":"Gershwin","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.clim.2019.04.009_bb0805","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/gut.2003.023937","article-title":"Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort","volume":"53","author":"Prince","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.clim.2019.04.009_bb0810","first-page":"94","article-title":"Diagnosis of Liver Involvement in Primary Sjogren Syndrome","volume":"1","author":"Zeron","year":"2013","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.clim.2019.04.009_bb0815","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0016-5085(85)90325-7","article-title":"Asymptomatic primary biliary cirrhosis: A progress report on long-term follow-up and natural history","volume":"89","author":"Beswick","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clim.2019.04.009_bb0820","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1093\/ndt\/16.12.2328","article-title":"Clinical and morphological features of kidney involvement in primary Sjogren's syndrome","volume":"16","author":"Bossini","year":"2001","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.clim.2019.04.009_bb0825","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/nrneph.2015.174","article-title":"Renal involvement in primary Sjogren syndrome","volume":"12","author":"Francois","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.clim.2019.04.009_bb0830","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1007\/s00296-018-4118-x","article-title":"Renal involvement in primary Sjogren's syndrome: a prospective cohort study","volume":"38","author":"Jain","year":"2018","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.clim.2019.04.009_bb0835","first-page":"362","article-title":"A multicentre study of 95 biopsy-proven cases of renal disease in primary Sjogren's syndrome","volume":"56","author":"Jasiek","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.clim.2019.04.009_bb0840","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.2215\/CJN.00980209","article-title":"Renal involvement in primary Sjogren's syndrome: a clinicopathologic study","volume":"4","author":"Maripuri","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.clim.2019.04.009_bb0845","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12891-015-0858-x","article-title":"Tubulointerstitial nephritis in primary Sjogren syndrome: clinical manifestations and response to treatment","volume":"17","author":"Evans","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.clim.2019.04.009_bb0850","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/rheumatology\/kev223","article-title":"Renal involvement in primary Sjogren's syndrome","volume":"54","author":"Evans","year":"2015","journal-title":"Rheumatology (Oxford, England)"},{"key":"10.1016\/j.clim.2019.04.009_bb0855","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/rheumatology\/keu401","article-title":"Prevalence of distal renal tubular acidosis in primary Sjogren's syndrome","volume":"54","author":"Both","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.clim.2019.04.009_bb0860","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/qjmed\/93.5.297","article-title":"Renal involvement in primary Sjogren's syndrome","volume":"93","author":"Aasarod","year":"2000","journal-title":"QJM"},{"key":"10.1016\/j.clim.2019.04.009_bb0865","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/rheumatology\/38.11.1113","article-title":"The occurrence of renal involvement in primary Sjogren's syndrome: a study of 78 patients","volume":"38","author":"Pertovaara","year":"1999","journal-title":"Rheumatology"},{"key":"10.1016\/j.clim.2019.04.009_bb0870","first-page":"278","article-title":"Renal involvement and followup of 130 patients with primary Sjogren's syndrome","volume":"35","author":"Ren","year":"2008","journal-title":"J Rheumatol"},{"issue":"Suppl. 112","key":"10.1016\/j.clim.2019.04.009_bb0875","first-page":"94","article-title":"Prevalence and spectrum of symptomatic pulmonary involvement in primary Sjogren's syndrome","volume":"36","author":"Kampolis","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb0880","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1183\/16000617.0011-2016","article-title":"Pulmonary manifestations of Sjogren's syndrome","volume":"25","author":"Flament","year":"2016","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.clim.2019.04.009_bb0885","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.autrev.2016.09.017","article-title":"Interstitial lung disease in primary Sjogren's syndrome","volume":"16","author":"Roca","year":"2017","journal-title":"Autoimmunity Rev"},{"key":"10.1016\/j.clim.2019.04.009_bb0890","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1093\/rheumatology\/kev200","article-title":"Characterization of systemic disease in primary Sjogren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements","volume":"54","author":"Ramos-Casals","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.clim.2019.04.009_bb0895","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1055\/s-0034-1371529","article-title":"Pulmonary involvement in Sjogren syndrome","volume":"35","author":"Kreider","year":"2014","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.clim.2019.04.009_bb0900","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1378\/chest.96.6.1440b","article-title":"Primary Sjogren syndrome and pleural effusion","volume":"96","author":"Alvarez-Sala","year":"1989","journal-title":"Chest"},{"key":"10.1016\/j.clim.2019.04.009_bb0905","doi-asserted-by":"crossref","first-page":"811","DOI":"10.2169\/internalmedicine.34.811","article-title":"Sjogren's syndrome with pleural effusion","volume":"34","author":"Ogihara","year":"1995","journal-title":"Intern Med"},{"key":"10.1016\/j.clim.2019.04.009_bb0910","first-page":"15322","article-title":"Primary Sjogren's syndrome accompanied by pleural effusion: a case report and literature review","volume":"8","author":"Ma","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.clim.2019.04.009_bb0915","first-page":"1484","article-title":"Primary Sjogren\u2019s syndrome causing pleural effusion","volume":"195","author":"Hadigal","year":"2017","journal-title":"Am J. Respir Crit Care Med"},{"key":"10.1016\/j.clim.2019.04.009_bb0920","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/MD.0b013e3181579781","article-title":"Pulmonary arterial hypertension: a rare complication of primary Sjogren syndrome: report of 9 new cases and review of the literature","volume":"86","author":"Launay","year":"2007","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clim.2019.04.009_bb0925","doi-asserted-by":"crossref","first-page":"504","DOI":"10.4070\/kcj.2013.43.7.504","article-title":"Severe pulmonary hypertension in primary Sjogren's syndrome","volume":"43","author":"Hwang","year":"2013","journal-title":"Korean Circ J"},{"key":"10.1016\/j.clim.2019.04.009_bb0930","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jaad.2018.05.021","article-title":"Cutaneous features and diagnosis of primary Sjogren syndrome: An update and review","volume":"79","author":"Jhorar","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clim.2019.04.009_bb0935","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1093\/rheumatology\/kew194","article-title":"Cryoglobulinaemic vasculitis at diagnosis predicts mortality in primary Sjogren syndrome: analysis of 515 patients","volume":"55","author":"Retamozo","year":"2016","journal-title":"Rheumatology"},{"key":"10.1016\/j.clim.2019.04.009_bb0940","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s40674-017-0076-9","article-title":"Neurological complications of Sjogren's syndrome: diagnosis and management","volume":"3","author":"McCoy","year":"2017","journal-title":"Curr Treatm Opt Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb0945","doi-asserted-by":"crossref","first-page":"99","DOI":"10.5114\/reum.2018.75521","article-title":"Neurological manifestations of primary Sjogren's syndrome","volume":"56","author":"Perzynska-Mazan","year":"2018","journal-title":"Reumatologia"},{"key":"10.1016\/j.clim.2019.04.009_bb0950","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084605","article-title":"Neurological involvement in primary Sjogren syndrome: a focus on central nervous system","volume":"9","author":"Morreale","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2019.04.009_bb0955","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/01.md.0000141099.53742.16","article-title":"Neurologic manifestations in primary Sjogren syndrome: a study of 82 patients","volume":"83","author":"Delalande","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clim.2019.04.009_bb0960","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1093\/brain\/awh605","article-title":"The wide spectrum of clinical manifestations in Sjogren's syndrome-associated neuropathy","volume":"128","author":"Mori","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.clim.2019.04.009_bb0965","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1097\/MD.0000000000000005","article-title":"Sjogren syndrome-associated small fiber neuropathy characterization from a prospective series of 40 cases","volume":"92","author":"Sene","year":"2013","journal-title":"Medicine"},{"key":"10.1016\/j.clim.2019.04.009_bb0970","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003632","article-title":"Sjogren sensory neuronopathy (Sjogren Ganglionopathy): long-term outcome and treatment response in a series of 13 cases","volume":"95","author":"Pereira","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clim.2019.04.009_bb0975","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S1474-4422(05)70249-0","article-title":"An update on the classification and treatment of vasculitic neuropathy","volume":"4","author":"Schaublin","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.clim.2019.04.009_bb0980","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/1759720X14566617","article-title":"Diagnosis and therapeutic options for peripheral vasculitic neuropathy","volume":"7","author":"Blaes","year":"2015","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.clim.2019.04.009_bb0985","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.jocn.2011.11.034","article-title":"Usefulness of superficial peroneal nerve\/peroneus brevis muscle biopsy in the diagnosis of vasculitic neuropathy","volume":"19","author":"Agadi","year":"2012","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.clim.2019.04.009_bb0990","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.clineuro.2005.05.015","article-title":"Subacute aseptic meningitis as neurological manifestation of primary Sjogren's syndrome","volume":"108","author":"Rossi","year":"2006","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.clim.2019.04.009_bb0995","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00296-014-3097-9","article-title":"Frequent involvement of central nervous system in primary Sjogren syndrome","volume":"35","author":"Moreira","year":"2015","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.clim.2019.04.009_bb1000","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-014-0200-5","article-title":"Sjogren's syndrome and Neuromyelitis Optica spectrum disorders (NMOSD) - a case report and review of literature","volume":"14","author":"Jayarangaiah","year":"2014","journal-title":"Bmc Neurology"},{"key":"10.1016\/j.clim.2019.04.009_bb1005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00415-013-7169-7","article-title":"Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS)","volume":"261","author":"Trebst","year":"2014","journal-title":"J Neurol"},{"key":"10.1016\/j.clim.2019.04.009_bb1010","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1136\/jnnp-2012-302310","article-title":"Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders","volume":"84","author":"Jacob","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl. 2","key":"10.1016\/j.clim.2019.04.009_bb1015","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1136\/annrheumdis-2018-eular.5535","article-title":"A summary of key findings from the Sjogren\u2019s Syndrome Foundation national patient survery related to treatments and medications used","volume":"77","author":"Taylor","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clim.2019.04.009_bb1020","first-page":"501327","article-title":"Cognitive dysfunction and dementia in primary Sjogren's Ssyndrome","author":"Blanc","year":"2013","journal-title":"ISRN Neurol"},{"key":"10.1016\/j.clim.2019.04.009_bb1025","first-page":"15","article-title":"Neuropsychological impairments in females with primary Sjogren\u2019s syndrome: New Insights","author":"Jennings","year":"2010","journal-title":"Prac Neurol"},{"key":"10.1016\/j.clim.2019.04.009_bb1030","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0889-857X(21)00321-5","article-title":"Central nervous system disease in Sjogren's syndrome. New insights into immunopathogenesis","volume":"18","author":"Alexander","year":"1992","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.clim.2019.04.009_bb1035","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00005792-198207000-00004","article-title":"Neurologic complications of primary Sjogren's syndrome","volume":"61","author":"Alexander","year":"1982","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clim.2019.04.009_bb1040","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s004150170135","article-title":"Neurological complications of primary Sjogren's syndrome","volume":"248","author":"Lafitte","year":"2001","journal-title":"J Neurol"},{"key":"10.1016\/j.clim.2019.04.009_bb1045","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1600-0404.2011.01530.x","article-title":"Primary Sjogren's syndrome: cognitive symptoms, mood, and cognitive performance","volume":"125","author":"Segal","year":"2012","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.clim.2019.04.009_bb1050","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1212\/WNL.31.11.1391","article-title":"Sjogren syndrome: central nervous system manifestations","volume":"31","author":"Alexander","year":"1981","journal-title":"Neurology"},{"key":"10.1016\/j.clim.2019.04.009_bb1055","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1007\/s00415-003-0153-x","article-title":"Magnetic resonance abnormalities associated with cognitive dysfunction in primary Sjogren syndrome","volume":"250","author":"Mataro","year":"2003","journal-title":"J Neurol"},{"key":"10.1016\/j.clim.2019.04.009_bb1060","first-page":"598","article-title":"Central Nervous System involvement in Sjogren\u2019s syndrome: evidence from neuropsychological testing and HMPAO-SPECT","volume":"150","author":"Belin","year":"1999","journal-title":"Ann Med Interne (Paris)"},{"key":"10.1016\/j.clim.2019.04.009_bb1065","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1207\/s15324826an0303&4_4","article-title":"Effective treatment of neuropsychological deficits in Sjogren's syndrome","volume":"3","author":"Johnstone","year":"1996","journal-title":"Appl Neuropsychol"},{"key":"10.1016\/j.clim.2019.04.009_bb1070","doi-asserted-by":"crossref","first-page":"344","DOI":"10.7326\/0003-4819-103-3-344","article-title":"Neuropsychiatric dysfunction in primary Sjogren's syndrome","volume":"103","author":"Malinow","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clim.2019.04.009_bb1075","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0002-9343(93)90255-N","article-title":"Neuropsychiatric disease in Sjogren's syndrome: anti-ribosomal P and anti-neuronal antibodies","volume":"95","author":"Spezialetti","year":"1993","journal-title":"Am J Med"},{"key":"10.1016\/j.clim.2019.04.009_bb1080","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1176\/jnp.11.2.241","article-title":"CNS Sjogren's syndrome: an underrecognized and underappreciated neuropsychiatric disorder","volume":"11","author":"Cox","year":"1999","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.clim.2019.04.009_bb1085","doi-asserted-by":"crossref","first-page":"815","DOI":"10.7326\/0003-4819-108-6-815","article-title":"Magnetic resonance imaging of cerebral lesions in patients with the Sjogren syndrome","volume":"108","author":"Alexander","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clim.2019.04.009_bb1090","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.586","article-title":"Cognition, depression, fatigue, and quality of life in primary Sjogren's syndrome: correlations","volume":"6","author":"Kocer","year":"2016","journal-title":"Brain Behav"},{"key":"10.1016\/j.clim.2019.04.009_bb1095","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2217\/ijr.10.99","article-title":"Cognitive disorders and brain MRI correlations in primary Sjogren\u2019s syndrome: unlocking the secret of cognitive symptoms","volume":"6","author":"Segal","year":"2011","journal-title":"Int J Clin Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb1100","series-title":"Prevalence and Demographic Characteristics of Sjogren's Syndrome in Colombia, Based on Information from the Official Ministry of Health Registry","author":"Fernandez-Avila","year":"2018"},{"key":"10.1016\/j.clim.2019.04.009_bb1105","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1007\/s10067-017-3745-z","article-title":"A systematic review of primary Sjogren's syndrome in male and paediatric populations","volume":"36","author":"Virdee","year":"2017","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb1110","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1136\/annrheumdis-2016-209952","article-title":"Influence of geolocation and ethnicity on the phenotypic expression of primary Sjogren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjogren Project Consortium","volume":"76","author":"Brito-Zeron","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clim.2019.04.009_bb1115","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/acr.22115","article-title":"Epidemiology of primary Sjogren's syndrome in a French multiracial\/multiethnic area","volume":"66","author":"Maldini","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.clim.2019.04.009_bb1120","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1002\/acr.23173","article-title":"Prevalence of Primary Sjogren's Syndrome in a US Population-Based Cohort","volume":"69","author":"Maciel","year":"2017","journal-title":"Arthritis Care Res"},{"issue":"Suppl. 2","key":"10.1016\/j.clim.2019.04.009_bb1125","doi-asserted-by":"crossref","first-page":"S196","DOI":"10.1097\/ICL.0000000000000448","article-title":"Survey of ophthalmologists regarding practice patterns for dry eye and Sjogren syndrome","volume":"44","author":"Bunya","year":"2018","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.clim.2019.04.009_bb1130","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.rdc.2016.03.010","article-title":"New treatment guidelines for Sjogren's disease","volume":"42","author":"Vivino","year":"2016","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.clim.2019.04.009_bb1135","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1093\/rheumatology\/kev200","article-title":"Characterization of systemic disease in primary Sjogren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements","volume":"54","author":"Ramos-Casals","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2019.04.009_bb1140","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/acr.22968","article-title":"Treatment guidelines for rheumatologic manifestations of Sjogren's syndrome: use of biologic agents, management of fatigue, and inflammatory musculoskeletal pain","volume":"69","author":"Carsons","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.clim.2019.04.009_bb1145","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.rbr.2015.07.004","article-title":"Recommendations for the treatment of Sjogren's syndrome","volume":"55","author":"Valim","year":"2015","journal-title":"Rev Bras Reumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb1150","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1093\/rheumatology\/kex375","article-title":"The British Society for Rheumatology guideline for the management of adults with primary Sjogren's Syndrome","volume":"56","author":"Price","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2019.04.009_bb1155","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1586\/1744666X.2016.1109449","article-title":"Early diagnosis of primary Sjogren's syndrome: EULAR-SS task force clinical recommendations","volume":"12","author":"Brito-Zeron","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb1160","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jtos.2014.12.001","article-title":"Clinical guidelines for management of dry eye associated with Sjogren disease","volume":"13","author":"Foulks","year":"2015","journal-title":"Ocul Surf"},{"key":"10.1016\/j.clim.2019.04.009_bb1165","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.adaj.2015.11.008","article-title":"Clinical practice guidelines for oral management of Sjogren disease: Dental caries prevention","volume":"147","author":"Zero","year":"2016","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.clim.2019.04.009_bb1170","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2018-000789","article-title":"Sjogren's syndrome: state of the art on clinical practice guidelines","volume":"4","author":"Romao","year":"2018","journal-title":"RMD Open"},{"key":"10.1016\/j.clim.2019.04.009_bb1175","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/rheumatology\/kep141","article-title":"Health-related quality of life, employment and disability in patients with Sjogren's syndrome","volume":"48","author":"Meijer","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2019.04.009_bb1180","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1136\/annrheumdis-2012-202863","article-title":"Health-related utility values of patients with primary Sjogren's syndrome and its predictors","volume":"73","author":"Lendrem","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clim.2019.04.009_bb1185","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/acr.22974","article-title":"Severe health-related quality of life impairment in active primary Sjogren's syndrome and patient-reported outcomes: data from a large therapeutic trial","volume":"69","author":"Cornec","year":"2017","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.clim.2019.04.009_bb1190","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/annrheumdis-2013-204615","article-title":"Validation of EULAR primary Sjogren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI)","volume":"74","author":"Seror","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clim.2019.04.009_bb1195","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7861\/clinmedicine.14-2-157","article-title":"A retrospective study of long-term outcomes in 152 patients with primary Sjogren's syndrome: 25-year experience","volume":"14","author":"Abrol","year":"2014","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.clim.2019.04.009_bb1200","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00296-017-3715-4","article-title":"Development of new extra-glandular manifestations or associated auto-immune diseases after establishing the diagnosis of primary Sjogren's syndrome : A long-term study of the Antonius Nieuwegein Sjogren (ANS) cohort","volume":"37","author":"Ter Borg","year":"2017","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.clim.2019.04.009_bb1205","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.semarthrit.2008.05.002","article-title":"Serum immunoglobulins and risk of infection: how low can you go?","volume":"39","author":"Furst","year":"2009","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.clim.2019.04.009_bb1210","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.semarthrit.2011.04.006","article-title":"Risk, predictors, and clinical characteristics of lymphoma development in primary Sjogren's syndrome","volume":"41","author":"Solans-Laque","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.clim.2019.04.009_bb1215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/039463200702000101","article-title":"BAFF and rheumatic autoimmune disorders: implications for disease management and therapy","volume":"20","author":"Bosello","year":"2007","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.clim.2019.04.009_bb1220","doi-asserted-by":"crossref","first-page":"e59868","DOI":"10.1371\/journal.pone.0059868","article-title":"Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjogren's syndrome. Data at enrollment in the prospective ASSESS cohort","volume":"8","author":"Gottenberg","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2019.04.009_bb1225","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.clim.2017.04.005","article-title":"Sjogren's syndrome: Clinical aspects","volume":"182","author":"Vivino","year":"2017","journal-title":"Clin Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb1230","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4103\/jcis.JCIS_45_18","article-title":"Review of the major and minor salivary glands, Part 1: anatomy, infectious, and inflammatory processes","volume":"8","author":"Kessler","year":"2018","journal-title":"J Clin Imaging Sci"},{"key":"10.1016\/j.clim.2019.04.009_bb1235","series-title":"World Workshop on Oral Medicine VII: Biomarkers predicting lymphoma in the salivary glands of patients with Sjogren's syndrome","author":"Delli","year":"2019"},{"key":"10.1016\/j.clim.2019.04.009_bb1240","first-page":"97","article-title":"Primary Sjogren's syndrome","volume":"379","author":"Mariette","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clim.2019.04.009_bb1245","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clim.2019.04.009_bb1250","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/acr.21591","article-title":"American College of Rheumatology classification criteria for Sjogren's syndrome: a data-driven, expert consensus approach in the Sjogren's International Collaborative Clinical Alliance cohort","volume":"64","author":"Shiboski","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.clim.2019.04.009_bb1255","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39859","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for Primary Sjogren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts","volume":"69","author":"Shiboski","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb1260","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s13075-017-1475-x","article-title":"Comparison of 2002 AECG and 2016 ACR\/EULAR classification criteria and added value of salivary gland ultrasonography in a patient cohort with suspected primary Sjogren's syndrome","volume":"19","author":"Le Goff","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.clim.2019.04.009_bb1265","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1001\/archopht.1969.00990020012003","article-title":"Diagnostic tests in the Sicca syndrome","volume":"82","author":"van Bijsterveld","year":"1969","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clim.2019.04.009_bb1270","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ajo.2009.09.013","article-title":"A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjogren's Syndrome International Registry","volume":"149","author":"Whitcher","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clim.2019.04.009_bb1275","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S1808-8694(15)31334-3","article-title":"Evaluation of sialometry and minor salivary gland biopsy in classification of Sjogren's Syndrome patients","volume":"71","author":"de Azevedo","year":"2005","journal-title":"Braz J Otorhinolaryngol"},{"key":"10.1016\/j.clim.2019.04.009_bb1280","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1136\/ard.60.12.1110","article-title":"Sialometry and sialochemistry: diagnostic tools for Sjogren's syndrome","volume":"60","author":"Kalk","year":"2001","journal-title":"Ann Rheum Dis"},{"issue":"973-986","key":"10.1016\/j.clim.2019.04.009_bb1285","first-page":"ix","article-title":"Role of nuclear scintigraphy in the characterization and management of the salivary component of Sjogren's syndrome","volume":"34","author":"Vivino","year":"2008","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.clim.2019.04.009_bb1290","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1001\/jama.1971.03180390021005","article-title":"Xerostomia in Sjogren's syndrome: Evaluation by sequential salivary scintigraphy","volume":"216","author":"Schall","year":"1971","journal-title":"JAMA"},{"key":"10.1016\/j.clim.2019.04.009_bb1295","first-page":"1260","article-title":"Variability of quantitative scintigraphic salivary indices in normal subjects","volume":"39","author":"Hermann","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1016\/j.clim.2019.04.009_bb1300","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/00006231-199912000-00004","article-title":"Scintigraphic features of chronic sialadenitis and Sjogren's syndrome: a comparison","volume":"20","author":"Hermann","year":"1999","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.clim.2019.04.009_bb1305","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1136\/annrheumdis-2016-210448","article-title":"Standardisation of labial salivary gland histopathology in clinical trials in primary Sjogren's syndrome","volume":"76","author":"Fisher","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clim.2019.04.009_bb1310","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1002\/art.30381","article-title":"Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjogren's syndrome among 1,726 registry participants","volume":"63","author":"Daniels","year":"2011","journal-title":"Arthritis Rheumatism"},{"key":"10.1016\/j.clim.2019.04.009_bb1315","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/ard.53.10.637","article-title":"The European Community Study Group on diagnostic criteria for Sjogren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjogren's syndrome","volume":"53","author":"Vitali","year":"1994","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clim.2019.04.009_bb1320","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1136\/jcp.21.5.656","article-title":"Labial salivary gland biopsy in Sjogren's disease","volume":"21","author":"Chisholm","year":"1968","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.clim.2019.04.009_bb1325","first-page":"938","article-title":"Change in final diagnosis on second evaluation of labial minor salivary gland biopsies","volume":"29","author":"Vivino","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb1330","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.coms.2013.09.005","article-title":"Salivary gland biopsy for Sjogren's syndrome","volume":"26","author":"Delli","year":"2014","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"10.1016\/j.clim.2019.04.009_bb1335","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.4317\/medoral.19131","article-title":"Minor salivary gland biopsy in Sjogren's syndrome: a review and introduction of a new tool to ease the procedure","volume":"19","author":"Varela-Centelles","year":"2014","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.clim.2019.04.009_bb1340","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1148\/radiology.169.3.3055038","article-title":"Parotid gland: US findings in Sjogren syndrome: Work in progress","volume":"169","author":"Bradus","year":"1988","journal-title":"Radiology"},{"issue":"Suppl. 112","key":"10.1016\/j.clim.2019.04.009_bb1345","first-page":"215","article-title":"Imaging in primary Sjogren's syndrome: the 'obsolete and the new'","volume":"36","author":"Baldini","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb1350","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1053\/j.sult.2012.11.012","article-title":"Sonography: the leading diagnostic tool for diseases of the salivary glands","volume":"34","author":"Zengel","year":"2013","journal-title":"Semin Ultrasound CT MR"},{"key":"10.1016\/j.clim.2019.04.009_bb1355","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2016-000364","article-title":"Salivary gland ultrasound abnormalities in primary Sjogren's syndrome: consensual US-SG core items definition and reliability","volume":"3","author":"Jousse-Joulin","year":"2017","journal-title":"RMD Open"},{"key":"10.1016\/j.clim.2019.04.009_bb1360","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1136\/annrheumdis-2017-211250","article-title":"Ultrasonography of major salivary glands compared with parotid and labial gland biopsy and classification criteria in patients with clinically suspected primary Sjogren's syndrome","volume":"76","author":"Mossel","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clim.2019.04.009_bb1365","first-page":"516","article-title":"Diagnostic accuracies of sialography and salivary ultrasonography in Sjogren's syndrome patients: a meta-analysis","volume":"32","author":"Song","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb1370","first-page":"56","article-title":"Diagnostic utility of major salivary gland ultrasonography in primary Sjogren's syndrome","volume":"33","author":"Hammenfors","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb1375","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/rheumatology\/ker431","article-title":"Ultrasonography of major salivary glands could be an alternative tool to sialoscintigraphy in the American-European classification criteria for primary Sjogren's syndrome","volume":"51","author":"Milic","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.clim.2019.04.009_bb1380","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/acr.21836","article-title":"American College of Rheumatology report on reasonable use of musculoskeletal ultrasonography in rheumatology clinical practice","volume":"64","author":"McAlindon","year":"2012","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.clim.2019.04.009_bb1385","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/rheumatology\/kev385","article-title":"Is salivary gland ultrasonography a useful tool in Sjogren's syndrome? A systematic review","volume":"55","author":"Jousse-Joulin","year":"2016","journal-title":"Rheumatology"},{"key":"10.1016\/j.clim.2019.04.009_bb1390","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1136\/annrheumdis-2017-211585","article-title":"The 2017 EULAR standardised procedures for ultrasound imaging in rheumatology","volume":"76","author":"Moller","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clim.2019.04.009_bb1395","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2214\/AJR.05.1549","article-title":"Sonographically guided core biopsy of a parotid mass","volume":"188","author":"Howlett","year":"2007","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.clim.2019.04.009_bb1400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cpf.12199","article-title":"Imaging of the major salivary glands","volume":"36","author":"Afzelius","year":"2016","journal-title":"Clin Physiol Funct Imaging"},{"key":"10.1016\/j.clim.2019.04.009_bb1405","doi-asserted-by":"crossref","first-page":"20130237","DOI":"10.1259\/dmfr.20130237","article-title":"Diagnostic value of CT perfusion imaging for parotid neoplasms","volume":"43","author":"Dong","year":"2014","journal-title":"Dentomaxillofac Radiol"},{"key":"10.1016\/j.clim.2019.04.009_bb1410","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaut.2013.11.001","article-title":"A comprehensive review of autoantibodies in primary Sjogren's syndrome: Clinical phenotypes and regulatory mechanisms","volume":"51C","author":"Kyriakidis","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.clim.2019.04.009_bb1415","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.autrev.2009.02.010","article-title":"Latest update on the Ro\/SS-A autoantibody system","volume":"8","author":"Schulte-Pelkum","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clim.2019.04.009_bb1420","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1002\/art.39214","article-title":"Prediction of Sjogren's Syndrome Years Before Diagnosis and Identification of Patients With Early Onset and Severe Disease Course by Autoantibody Profiling","volume":"67","author":"Theander","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb1425","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1136\/annrheumdis-2014-206683","article-title":"The SSB-positive\/SSA-negative antibody profile is not associated with key phenotypic features of Sjogren's syndrome","volume":"74","author":"Baer","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clim.2019.04.009_bb1430","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1172\/JCI112892","article-title":"Implications of anti-Ro\/Sjogren's syndrome A antigen autoantibody in normal sera for autoimmunity","volume":"79","author":"Gaither","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clim.2019.04.009_bb1435","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.autrev.2018.09.003","article-title":"Novel autoantibodies in Sjogren's syndrome: A comprehensive review","volume":"18","author":"Martin-Nares","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clim.2019.04.009_bb1440","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.clim.2017.03.017","article-title":"Autoantibodies, detection methods and panels for diagnosis of Sjogren's syndrome","volume":"182","author":"Shen","year":"2017","journal-title":"Clin Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb1445","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.4049\/jimmunol.177.8.5676","article-title":"Development of autoimmunity in IL-14alpha-transgenic mice","volume":"177","author":"Shen","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb1450","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.clim.2014.08.009","article-title":"Evaluation of salivary gland protein 1 antibodies in patients with primary and secondary Sjogren's syndrome","volume":"155","author":"Shen","year":"2014","journal-title":"Clin Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb1455","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.clim.2012.09.013","article-title":"Novel autoantibodies in Sjogren's syndrome","volume":"145","author":"Shen","year":"2012","journal-title":"Clin Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb1460","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1741-2358.1997.00033.x","article-title":"A reference guide to drugs and dry mouth--2nd edition","volume":"14","author":"Sreebny","year":"1997","journal-title":"Gerodontology"},{"key":"10.1016\/j.clim.2019.04.009_bb1465","first-page":"1","article-title":"Xerostomia: prevalence and pharmacotherapy. With special reference to beta-adrenoceptor antagonists","volume":"116","author":"Nederfors","year":"1996","journal-title":"Swed Dent J Suppl"},{"key":"10.1016\/j.clim.2019.04.009_bb1470","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.bjoms.2008.01.014","article-title":"Sialosis: 35 cases of persistent parotid swelling from two countries","volume":"46","author":"Scully","year":"2008","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.clim.2019.04.009_bb1475","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.14219\/jada.archive.1997.0060","article-title":"Alcoholic parotid sialadenosis","volume":"128","author":"Mandel","year":"1997","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.clim.2019.04.009_bb1480","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/rheumatology\/36.12.1312","article-title":"Chronic sialadenitis in patients with nodal osteoarthritis","volume":"36","author":"Kassimos","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb1485","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.coms.2009.05.001","article-title":"The bacteriology of salivary gland infections","volume":"21","author":"Brook","year":"2009","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"10.1016\/j.clim.2019.04.009_bb1490","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1093\/infdis\/jit408","article-title":"Viruses detected among sporadic cases of parotitis, United States, 2009-2011","volume":"208","author":"Barskey","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clim.2019.04.009_bb1495","first-page":"68","article-title":"A case of HIV-associated diffuse infiltrative lymphocytosis syndrome simulating primary Sjogren syndrome and BALT Lymphoma","volume":"40","author":"Rovisco","year":"2015","journal-title":"Acta Reumatol Port"},{"issue":"869-884","key":"10.1016\/j.clim.2019.04.009_bb1500","first-page":"vii","article-title":"Hepatitis C virus and Sjogren's syndrome: trigger or mimic?","volume":"34","author":"Ramos-Casals","year":"2008","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.clim.2019.04.009_bb1505","first-page":"6936727","article-title":"Salivary gland pathology in IgG4-related disease: a comprehensive review","author":"Puxeddu","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1016\/j.clim.2019.04.009_bb1510","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2214\/AJR.16.16058","article-title":"Sarcoidosis in the head and neck: an illustrative review of clinical presentations and imaging findings","volume":"208","author":"Chapman","year":"2017","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.clim.2019.04.009_bb1515","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-221869","article-title":"HIV-associated benign lymphoepithelial cysts of the parotid glands confirmed by HIV-1 p24 antigen immunostaining","author":"Sekikawa","year":"2017","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.clim.2019.04.009_bb1520","article-title":"Genetics and epigenetics in primary Sjogren's syndrome","author":"Imgenberg-Kreuz","year":"2019","journal-title":"Rheumatology"},{"key":"10.1016\/j.clim.2019.04.009_bb1525","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.4049\/jimmunol.150.8.3615","article-title":"Comparison of HLA class II genes in Caucasoid, Chinese, and Japanese patients with primary Sjogren's syndrome","volume":"150","author":"Kang","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb1530","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/art.40040","article-title":"Genome-wide association analysis reveals genetic heterogeneity of Sjogren's syndrome according to ancestry","volume":"69","author":"Taylor","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb1535","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.rdc.2008.08.003","article-title":"Genes and Sjogren's syndrome","volume":"34","author":"Cobb","year":"2008","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.clim.2019.04.009_bb1540","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.autrev.2011.10.002","article-title":"HLA and Sjogren's syndrome susceptibility. A meta-analysis of worldwide studies","volume":"11","author":"Cruz-Tapias","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clim.2019.04.009_bb1545","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/ng.2792","article-title":"Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjogren's syndrome","volume":"45","author":"Lessard","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.clim.2019.04.009_bb1550","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/ng.2779","article-title":"A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjogren's syndrome at 7q11.23","volume":"45","author":"Li","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.clim.2019.04.009_bb1555","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1002\/art.11103","article-title":"In primary Sjogren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response","volume":"48","author":"Gottenberg","year":"2003","journal-title":"Arthritis Rheumatism"},{"key":"10.1016\/j.clim.2019.04.009_bb1560","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/imr.12328","article-title":"Genetics, genomics, and evolutionary biology of NKG2D ligands","volume":"267","author":"Carapito","year":"2015","journal-title":"Immunol Rev"},{"key":"10.1016\/j.clim.2019.04.009_bb1565","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000518","article-title":"In vivo expression pattern of MICA and MICB and its relevance to auto-immunity and cancer","volume":"2","author":"Schrambach","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2019.04.009_bb1570","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1093\/hmg\/ddx135","article-title":"A new MHC-linked susceptibility locus for primary Sjogren's syndrome: MICA","volume":"26","author":"Carapito","year":"2017","journal-title":"Hum Mol Gen"},{"key":"10.1016\/j.clim.2019.04.009_bb1575","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/gene.2009.20","article-title":"Peripheral blood gene expression profiling in Sjogren's syndrome","volume":"10","author":"Emamian","year":"2009","journal-title":"Genes Immunity"},{"key":"10.1016\/j.clim.2019.04.009_bb1580","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/annrheumdis-2012-201381","article-title":"Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression","volume":"72","author":"Brkic","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clim.2019.04.009_bb1585","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nature03308","article-title":"Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors","volume":"434","author":"Takaoka","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.clim.2019.04.009_bb1590","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1146\/annurev.immunol.19.1.623","article-title":"IRF family of transcription factors as regulators of host defense","volume":"19","author":"Taniguchi","year":"2001","journal-title":"Ann Rev Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb1595","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1002\/art.23142","article-title":"Association of an IRF5 gene functional polymorphism with Sjogren's syndrome","volume":"56","author":"Miceli-Richard","year":"2007","journal-title":"Arthritis Rheumatism"},{"key":"10.1016\/j.clim.2019.04.009_bb1600","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/gene.2008.94","article-title":"Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sj\u00f6gren's syndrome","volume":"10","author":"Nordmark","year":"2009","journal-title":"Genes Immun"},{"key":"10.1016\/j.clim.2019.04.009_bb1605","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1002\/art.24662","article-title":"The CGGGG insertion\/deletion polymorphism of the IRF5 promoter is a strong risk factor for primary Sjogren's syndrome","volume":"60","author":"Miceli-Richard","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clim.2019.04.009_bb1610","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/hmg\/ddm359","article-title":"Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus","volume":"17","author":"Sigurdsson","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.clim.2019.04.009_bb1615","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/gene.2010.44","article-title":"Association of EBF1, FAM167A(C8orf13)-BLK and TNFSF4 gene variants with primary Sjogren's syndrome","volume":"12","author":"Nordmark","year":"2011","journal-title":"Genes Immun"},{"key":"10.1016\/j.clim.2019.04.009_bb1620","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/hmg\/ddu455","article-title":"The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share","volume":"24","author":"Kottyan","year":"2015","journal-title":"Hum Mol Gen"},{"key":"10.1016\/j.clim.2019.04.009_bb1625","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/gene.2008.1","article-title":"Variant form of STAT4 is associated with primary Sjogren's syndrome","volume":"9","author":"Korman","year":"2008","journal-title":"Genes Immunity"},{"key":"10.1016\/j.clim.2019.04.009_bb1630","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.3899\/jrheum.091007","article-title":"Influence of STAT4 polymorphism in primary Sjogren's syndrome","volume":"37","author":"Palomino-Morales","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb1635","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/gene.2010.29","article-title":"STAT4 is a confirmed genetic risk factor for Sjogren's syndrome and could be involved in type 1 interferon pathway signaling","volume":"11","author":"Gestermann","year":"2010","journal-title":"Genes Immun"},{"key":"10.1016\/j.clim.2019.04.009_bb1640","article-title":"Regulation of antitumor immune responses by the IL-12 family cytokines, IL-12, IL-23, and IL-27","volume":"2010","author":"Xu","year":"2010","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb1645","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.0105-2896.2004.00211.x","article-title":"Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4","volume":"202","author":"Watford","year":"2004","journal-title":"Immunol Rev"},{"key":"10.1016\/j.clim.2019.04.009_bb1650","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006820","article-title":"Identification of a Sjogren's syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons","volume":"13","author":"Li","year":"2017","journal-title":"PLoS Genet"},{"key":"10.1016\/j.clim.2019.04.009_bb1655","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrrheum.2018.1","article-title":"B cells in the pathogenesis of primary Sjogren syndrome","volume":"14","author":"Nocturne","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb1660","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/ard.62.2.168","article-title":"The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren's syndrome","volume":"62","author":"Mariette","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clim.2019.04.009_bb1665","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1196\/annals.1313.004","article-title":"BAFF overexpression is associated with autoantibody production in autoimmune diseases","volume":"1050","author":"Pers","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.clim.2019.04.009_bb1670","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1084\/jem.189.11.1747","article-title":"BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth","volume":"189","author":"Schneider","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.clim.2019.04.009_bb1675","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1172\/JCI0214121","article-title":"Association of BAFF\/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome","volume":"109","author":"Groom","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clim.2019.04.009_bb1680","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nri844","article-title":"BAFF: a fundamental survival factor for B cells","volume":"2","author":"Mackay","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb1685","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/rheumatology\/ken246","article-title":"Polymorphism in the 5' regulatory region of the B-lymphocyte activating factor gene is associated with the Ro\/La autoantibody response and serum BAFF levels in primary Sjogren's syndrome","volume":"47","author":"Nossent","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.clim.2019.04.009_bb1690","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jaut.2013.04.005","article-title":"B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome","volume":"51","author":"Nezos","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.clim.2019.04.009_bb1695","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005727","article-title":"NCR3\/NKp30 contributes to pathogenesis in primary Sjogren's syndrome","volume":"5","author":"Rusakiewicz","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.clim.2019.04.009_bb1700","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1002\/art.34642","article-title":"Association of two independent functional risk haplotypes in TNIP1 with systemic lupus erythematosus","volume":"64","author":"Adrianto","year":"2012","journal-title":"Arthritis Rheumatism"},{"key":"10.1016\/j.clim.2019.04.009_bb1705","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/cei.13138","article-title":"The rheumatic disease-associated FAM167A-BLK locus encodes DIORA-1, a novel disordered protein expressed highly in bronchial epithelium and alveolar macrophages","volume":"193","author":"Mentlein","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb1710","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/art.21006","article-title":"Gene expression profiling of minor salivary glands clearly distinguishes primary Sjogren's syndrome patients from healthy control subjects","volume":"52","author":"Hjelmervik","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clim.2019.04.009_bb1715","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12662","article-title":"Transcription profiling of peripheral B cells in antibody-positive primary Sjogren's syndrome reveals upregulated expression of CX3CR1 and a type I and type II interferon signature","volume":"87","author":"Imgenberg-Kreuz","year":"2018","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb1720","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/cei.13118","article-title":"Diminished CXCR5 expression in peripheral blood of patients with Sjogren's syndrome may relate to both genotype and salivary gland homing","volume":"192","author":"Aqrawi","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb1725","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/annrheumdis-2015-207731","article-title":"Germline variation of TNFAIP3 in primary Sjogren's syndrome-associated lymphoma","volume":"75","author":"Nocturne","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clim.2019.04.009_bb1730","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/ng.2792","article-title":"Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjogren's syndrome","volume":"45","author":"Lessard","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.clim.2019.04.009_bb1735","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/ng.766","article-title":"Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus","volume":"43","author":"Adrianto","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.clim.2019.04.009_bb1740","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0006-2952(00)00404-4","article-title":"A20 and A20-binding proteins as cellular inhibitors of nuclear factor-kappa B-dependent gene expression and apoptosis","volume":"60","author":"Beyaert","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.clim.2019.04.009_bb1745","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.clim.2016.04.002","article-title":"Klinefelter's syndrome (47,XXY) is in excess among men with Sjogren's syndrome","volume":"168","author":"Harris","year":"2016","journal-title":"Clin Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb1750","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/art.39560","article-title":"X chromosome dose and sex bias in autoimmune diseases","volume":"68","author":"Liu","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb1755","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/art.40207","article-title":"Rare X chromosome abnormalities in systemic lupus erythematosus and Sjogren's syndrome","volume":"69","author":"Sharma","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb1760","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177320","article-title":"Common variants near IKZF1 are associated with primary Sjogren's syndrome in Han Chinese","volume":"12","author":"Qu","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2019.04.009_bb1765","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s12016-014-8431-1","article-title":"The differential diagnosis of dry eyes, dry mouth, and parotidomegaly: a comprehensive review","volume":"49","author":"Cornec","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb1770","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.immuni.2014.05.010","article-title":"Macrophages, Immunity, and Metabolic Disease","volume":"41","author":"McNelis","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2019.04.009_bb1775","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-1-4615-4857-7_18","article-title":"Sjogren's syndrome. Autoimmune epithelitis","volume":"455","author":"Tapinos","year":"1999","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.clim.2019.04.009_bb1780","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.4049\/jimmunol.1401880","article-title":"Natural IgM prevents autoimmunity by enforcing B cell central tolerance induction","volume":"194","author":"Nguyen","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb1785","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1007\/s10875-014-0025-4","article-title":"Natural IgM: beneficial autoantibodies for the control of inflammatory and autoimmune disease","volume":"34","author":"Gronwall","year":"2014","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb1790","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nri3802","article-title":"Memory B cells","volume":"15","author":"Kurosaki","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb1795","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","article-title":"Central memory and effector memory T cell subsets: Function, generation, and maintenance","volume":"22","author":"Sallusto","year":"2004","journal-title":"Ann Rev Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb1800","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"New Eng J Med"},{"key":"10.1016\/j.clim.2019.04.009_bb1805","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1002\/art.39214","article-title":"Prediction of Sjogren's syndrome years before diagnosis and identification of patients with early onset and severe disease course by autoantibody profiling","volume":"67","author":"Theander","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb1810","doi-asserted-by":"crossref","first-page":"7538","DOI":"10.1073\/pnas.95.13.7538","article-title":"Transfer of human serum IgG to nonobese diabetic Igmu null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjogren's syndrome","volume":"95","author":"Robinson","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clim.2019.04.009_bb1815","doi-asserted-by":"crossref","DOI":"10.1186\/ar3313","article-title":"Sjogren's syndrome: studying the disease in mice","volume":"13","author":"Delaleu","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.clim.2019.04.009_bb1820","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s12016-011-8288-5","article-title":"Animal models in autoimmune diseases: lessons learned from mouse models for Sjogren's syndrome","volume":"42","author":"Lee","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb1825","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1586\/1744666X.2014.883920","article-title":"The value of animal models to study immunopathology of primary human Sjogren's syndrome symptoms","volume":"10","author":"Donate","year":"2014","journal-title":"Exp Rev Clin Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb1830","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-015-0678-2","article-title":"The clinical relevance of animal models in Sjogren's syndrome: the interferon signature from mouse to man","volume":"17","author":"Maria","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.clim.2019.04.009_bb1835","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0952-7915(99)00039-4","article-title":"Genetic dissection of systemic lupus erythematosus","volume":"11","author":"Wakeland","year":"1999","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb1840","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/art.23368","article-title":"Inflammatory stimuli accelerate Sjogren's syndrome-like disease in (NZB x NZW)F-1 mice","volume":"58","author":"Deshmukh","year":"2008","journal-title":"Arthritis Rheumatism"},{"key":"10.1016\/j.clim.2019.04.009_bb1845","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.autrev.2010.02.007","article-title":"The autoimmune lymphoproliferative syndrome: A rare disorder providing clues about normal tolerance","volume":"9","author":"Turbyville","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clim.2019.04.009_bb1850","first-page":"1437","article-title":"Murine models of Sjogren's syndrome. Immunohistologic analysis of different strains","volume":"29","author":"Jabs","year":"1988","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clim.2019.04.009_bb1855","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaut.2005.11.004","article-title":"Sjogren's syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease","volume":"26","author":"Gao","year":"2006","journal-title":"J Autoimmun"},{"key":"10.1016\/j.clim.2019.04.009_bb1860","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00281-010-0204-1","article-title":"Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease","volume":"33","author":"Driver","year":"2011","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.clim.2019.04.009_bb1865","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/art.10258","article-title":"Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjogren's syndrome) on a healthy murine background","volume":"46","author":"Cha","year":"2002","journal-title":"Arthritis Rheumatism"},{"key":"10.1016\/j.clim.2019.04.009_bb1870","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/mi.2016.83","article-title":"Age-related spontaneous lacrimal keratoconjunctivitis is accompanied by dysfunctional T regulatory cells","volume":"10","author":"Coursey","year":"2016","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb1875","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.clim.2016.01.015","article-title":"Early BAFF receptor blockade mitigates murine Sjogren's syndrome: Concomitant targeting of CXCL13 and the BAFF receptor prevents salivary hypofunction","volume":"164","author":"Sharma","year":"2016","journal-title":"Clin Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb1880","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.4049\/jimmunol.1001388","article-title":"Inhibition of autoimmune diabetes by TLR2 tolerance","volume":"187","author":"Kim","year":"2011","journal-title":"Journal of immunology"},{"key":"10.1016\/j.clim.2019.04.009_bb1885","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019962","article-title":"Effect of soluble ICAM-1 on a Sjogren's syndrome-like phenotype in NOD mice is disease stage dependent","volume":"6","author":"Roescher","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2019.04.009_bb1890","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-3083.2006.01828.x","article-title":"Sjogren's syndrome-like disease of C57BL\/6.NOD-Aec1Aec2 mice: Gender differences in keratoconjunctivitis sicca defined by a cross-over in the chromosome 3 Aec1 locus","volume":"64","author":"Nguyen","year":"2006","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb1895","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.1167\/iovs.11-7652","article-title":"Gene expression profiling of early-phase Sjogren's syndrome in C57BL\/6.NOD-Aec1Aec2 mice identifies focal adhesion maturation associated with infiltrating leukocytes","volume":"52","author":"Peck","year":"2011","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"10.1016\/j.clim.2019.04.009_bb1900","doi-asserted-by":"crossref","first-page":"R174","DOI":"10.1186\/ar4362","article-title":"Transcriptional landscapes of emerging autoimmunity: transient aberrations in the targeted tissue's extracellular milieu precede immune responses in Sjogren's syndrome","volume":"15","author":"Delaleu","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.clim.2019.04.009_bb1905","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1177\/0022034513483315","article-title":"Type I interferon receptor deficiency prevents murine Sjogren's syndrome","volume":"92","author":"Szczerba","year":"2013","journal-title":"J Dent Res"},{"key":"10.1016\/j.clim.2019.04.009_bb1910","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/BOR.0b013e328349fd30","article-title":"Activation of the type I interferon pathway in primary Sjogren's syndrome: an update","volume":"23","author":"Vakaloglou","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb1915","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/BOR.0000000000000524","article-title":"An update on the role of type I interferons in systemic lupus erythematosus and Sjogren's syndrome","volume":"30","author":"Thorlacius","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb1920","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/BOR.0b013e32836200d2","article-title":"Autoimmunity and infection in Sjogren's syndrome","volume":"25","author":"Igoe","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb1925","doi-asserted-by":"crossref","first-page":"7391","DOI":"10.4049\/jimmunol.177.10.7391","article-title":"Severe focal sialadenitis and dacryoadenitis in NZM2328 mice induced by MCMV: a novel model for human Sjogren's syndrome","volume":"177","author":"Ohyama","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb1930","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3389\/fimmu.2013.00142","article-title":"The interferon-signature of Sjogren's Syndrome: how unique biomarkers can identify underlying inflammatory and immunopathological mechanisms of specific diseases","volume":"4","author":"Nguyen","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb1935","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.0105-2896.2005.00219.x","article-title":"The role of BAFF in immune function and implications for autoimmunity","volume":"204","author":"Kalled","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.clim.2019.04.009_bb1940","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1084\/jem.190.11.1697","article-title":"Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations","volume":"190","author":"Mackay","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.clim.2019.04.009_bb1945","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.pharmthera.2006.06.002","article-title":"Targeting BAFF: immunomodulation for autoimmune diseases and lymphomas","volume":"112","author":"Sutherland","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.clim.2019.04.009_bb1950","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1002\/eji.200636270","article-title":"Development of nephritis but not sialadenitis in autoimmune-prone BAFF transgenic mice lacking marginal zone B cells","volume":"36","author":"Fletcher","year":"2006","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb1955","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.4049\/jimmunol.1001520","article-title":"A role for lymphotoxin in primary Sjogren's disease","volume":"185","author":"Shen","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb1960","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1146\/annurev.immunol.23.021704.115728","article-title":"Marginal zone B cells","volume":"23","author":"Pillai","year":"2005","journal-title":"Ann Rev Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb1965","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.clim.2016.04.008","article-title":"Central role for marginal zone B cells in an animal model of Sjogren's syndrome","volume":"168","author":"Shen","year":"2016","journal-title":"Clin Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb1970","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.clim.2008.10.006","article-title":"IL-14 alpha, the nexus for primary Sjogren's disease in mice and humans","volume":"130","author":"Shen","year":"2009","journal-title":"Clin Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb1975","doi-asserted-by":"crossref","first-page":"608","DOI":"10.4049\/jimmunol.1203440","article-title":"Different stages of primary Sjogren's syndrome involving lymphotoxin and Type 1 IFN","volume":"191","author":"Shen","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb1980","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39859","article-title":"American college of rheumatology\/european league against rheumatism classification criteria for primary Sjogren's syndrome A consensus and data-driven methodology involving three international patient cohorts","volume":"69","author":"Shiboski","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb1985","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.clim.2014.08.009","article-title":"Evaluation of salivary gland protein 1 antibodies in patients with primary and secondary Sjogren's syndrome","volume":"155","author":"Shen","year":"2014","journal-title":"Clin Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb1990","doi-asserted-by":"crossref","DOI":"10.1186\/s12886-015-0023-1","article-title":"Investigation of novel autoantibodies in Sjogren's syndrome utilizing Sera from the Sjogren's international collaborative clinical alliance cohort","volume":"15","author":"Suresh","year":"2015","journal-title":"Bmc Ophthalmol"},{"key":"10.1016\/j.clim.2019.04.009_bb1995","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12886-017-0412-8","article-title":"Analysis of novel Sjogren's syndrome autoantibodies in patients with dry eyes","volume":"17","author":"Everett","year":"2017","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.clim.2019.04.009_bb2000","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jim.2016.07.003","article-title":"Muscarinic type 3 receptor autoantibodies are associated with anti-SSA\/Ro autoantibodies in Sjogren's syndrome","volume":"437","author":"Zuo","year":"2016","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.clim.2019.04.009_bb2005","doi-asserted-by":"crossref","first-page":"8409","DOI":"10.4049\/jimmunol.175.12.8409","article-title":"Immunization with short peptides from the 60-kDa Ro antigen recapitulates the serological and pathological findings as well as the salivary gland dysfunction of Sjogren's syndrome","volume":"175","author":"Scofield","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb2010","doi-asserted-by":"crossref","first-page":"e461","DOI":"10.1016\/j.lpm.2012.05.019","article-title":"Pathogenic role of anti-M3 muscarinic acetylcholine receptor immune response in Sjogren's syndrome","volume":"41","author":"Sumida","year":"2012","journal-title":"Presse Med"},{"key":"10.1016\/j.clim.2019.04.009_bb2015","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/BOR.0b013e32832eba21","article-title":"Pathogenesis of Sjogren's syndrome","volume":"21","author":"Nikolov","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb2020","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1385\/JMN:30:1:157","article-title":"M1-M3 muscarinic acetylcholine receptor-deficient mice: novel phenotypes","volume":"30","author":"Gautam","year":"2006","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.clim.2019.04.009_bb2025","doi-asserted-by":"crossref","first-page":"23413","DOI":"10.1074\/jbc.M008760200","article-title":"Salivary acinar cells from aquaporin 5-deficient mice have decreased membrane water permeability and altered cell volume regulation","volume":"276","author":"Krane","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clim.2019.04.009_bb2030","doi-asserted-by":"crossref","first-page":"26720","DOI":"10.1016\/S0021-9258(19)61435-3","article-title":"Severe impairment of salivation in Na+\/K+\/2Cl- cotransporter (NKCC1)-deficient mice","volume":"275","author":"Evans","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clim.2019.04.009_bb2035","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1126\/science.1114110","article-title":"IP3 receptor types 2 and 3 mediate exocrine secretion underlying energy metabolism","volume":"309","author":"Futatsugi","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.clim.2019.04.009_bb2040","article-title":"Matriptase deletion initiates a Sjogren's syndrome-like disease in mice","volume":"9","author":"Yin","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2019.04.009_bb2045","doi-asserted-by":"crossref","first-page":"16882","DOI":"10.1073\/pnas.0607984103","article-title":"Sjogren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase","volume":"103","author":"Oak","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clim.2019.04.009_bb2050","doi-asserted-by":"crossref","first-page":"14544","DOI":"10.1073\/pnas.1207354109","article-title":"STIM1 and STIM2 protein deficiency in T lymphocytes underlies development of the exocrine gland autoimmune disease, Sjogren's syndrome","volume":"109","author":"Cheng","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clim.2019.04.009_bb2055","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.immuni.2004.10.003","article-title":"Id3 knockout mice as a new model for sjogren's syndrome: only a T cell defect or more?","volume":"21","author":"Versnel","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2019.04.009_bb2060","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1002\/art.24980","article-title":"Interleukin-12 induces salivary gland dysfunction in transgenic mice, providing a new model of Sjogren's syndrome","volume":"60","author":"Vosters","year":"2009","journal-title":"Arthritis Rheumatism"},{"key":"10.1016\/j.clim.2019.04.009_bb2065","doi-asserted-by":"crossref","first-page":"R189","DOI":"10.1186\/ar2888","article-title":"Local expression of tumor necrosis factor-receptor 1:immunoglobulin G can induce salivary gland dysfunction in a murine model of Sjogren's syndrome","volume":"11","author":"Vosters","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.clim.2019.04.009_bb2070","first-page":"1884","article-title":"Possible function of salivary gland epithelial cells as nonprofessional antigen-presenting cells in the development of Sjogren's syndrome","volume":"29","author":"Tsunawaki","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb2075","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/joim.12115","article-title":"The P2X7 receptor-inflammasome complex has a role in modulating the inflammatory response in primary Sjogren's syndrome","volume":"274","author":"Baldini","year":"2013","journal-title":"J Intern Med"},{"key":"10.1016\/j.clim.2019.04.009_bb2080","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1006\/clin.1994.1123","article-title":"Sjogren's syndrome: autoimmune epithelitis","volume":"72","author":"Moutsopoulos","year":"1994","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.clim.2019.04.009_bb2085","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2013.02.001","article-title":"Sjogren's syndrome and the epithelial target: a comprehensive review","volume":"42","author":"Barrera","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.clim.2019.04.009_bb2090","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/art.27362","article-title":"Disruption of tight junction structure in salivary glands from Sjogren's syndrome patients is linked to proinflammatory cytokine exposure","volume":"62","author":"Ewert","year":"2010","journal-title":"Arthritis Rheumatism"},{"key":"10.1016\/j.clim.2019.04.009_bb2095","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jaut.2012.01.011","article-title":"Aberrant localization of fusion receptors involved in regulated exocytosis in salivary glands of Sjogren's syndrome patients is linked to ectopic mucin secretion","volume":"39","author":"Barrera","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.clim.2019.04.009_bb2100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01.LAB.0000048721.21475.D1","article-title":"Apoptosis and apoptosis-related molecules in the submandibular gland of the nonobese diabetic mouse model for Sjogren's syndrome: limited role for apoptosis in the development of sialoadenitis","volume":"83","author":"Van Blokland","year":"2003","journal-title":"Lab Invest"},{"key":"10.1016\/j.clim.2019.04.009_bb2105","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.immuni.2012.11.016","article-title":"Enhanced apoptosis by disruption of the STAT3-IkappaB-zeta signaling pathway in epithelial cells induces Sjogren's syndrome-like autoimmune disease","volume":"38","author":"Okuma","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2019.04.009_bb2110","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jaut.2010.06.010","article-title":"Salivary epithelial cells from Sjogren's syndrome patients are highly sensitive to anoikis induced by TLR-3 ligation","volume":"35","author":"Manoussakis","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.clim.2019.04.009_bb2115","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yexcr.2018.12.027","article-title":"Toll-like receptor 9 signaling promotes autophagy and apoptosis via divergent functions of the p38\/JNK pathway in human salivary gland cells","volume":"375","author":"Fu","year":"2019","journal-title":"Exp Cell Res."},{"key":"10.1016\/j.clim.2019.04.009_bb2120","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1177\/0022034515590796","article-title":"The role of autophagy in salivary gland homeostasis and stress responses","volume":"94","author":"Morgan-Bathke","year":"2015","journal-title":"J Dent Res"},{"key":"10.1016\/j.clim.2019.04.009_bb2125","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17128-0","article-title":"Elevation of autophagy markers in Sjogren syndrome dry eye","volume":"7","author":"Byun","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.clim.2019.04.009_bb2130","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/cei.12638","article-title":"Endoplasmic reticulum stress causes autophagy and apoptosis leading to cellular redistribution of the autoantigens Ro\/Sjogren's syndrome-related antigen A (SSA) and La\/SSB in salivary gland epithelial cells","volume":"181","author":"Katsiougiannis","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb2135","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3390\/cells2010083","article-title":"Divergent roles of autophagy in virus infection","volume":"2","author":"Chiramel","year":"2013","journal-title":"Cells"},{"key":"10.1016\/j.clim.2019.04.009_bb2140","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1172\/JCI41474","article-title":"Activation of the unfolded protein response and autophagy after hepatitis C virus infection suppresses innate antiviral immunity in vitro","volume":"121","author":"Ke","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clim.2019.04.009_bb2145","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1053\/j.gastro.2017.06.011","article-title":"Restoration of CFTR activity in ducts rescues acinar cell function and reduces inflammation in pancreatic and salivary glands of mice","volume":"153","author":"Zeng","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clim.2019.04.009_bb2150","first-page":"354","article-title":"The expression of P2X7 receptors on peripheral blood mononuclear cells in patients with primary Sjogren's syndrome and its correlation with anxiety and depression","volume":"32","author":"Xie","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb2155","doi-asserted-by":"crossref","first-page":"16626","DOI":"10.1074\/jbc.M117.790741","article-title":"P2X7 receptor antagonism prevents IL-1 beta release from salivary epithelial cells and reduces inflammation in a mouse model of autoimmune exocrinopathy","volume":"292","author":"Khalafalla","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clim.2019.04.009_bb2160","doi-asserted-by":"crossref","first-page":"5694","DOI":"10.1073\/pnas.1601992113","article-title":"Aquaporin gene therapy corrects Sjogren's syndrome phenotype in mice","volume":"113","author":"Lai","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.clim.2019.04.009_bb2165","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1089\/scd.2017.0161","article-title":"Effect of bone morphogenetic protein 6 on immunomodulatory functions of salivary gland-derived mesenchymal stem cells in Sjogren's syndrome","volume":"27","author":"Xu","year":"2018","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.clim.2019.04.009_bb2170","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9837035","article-title":"Bone morphogenetic protein 6 inhibits the immunomodulatory property of BMMSCs via Id1 in Sjogren's syndrome","volume":"2018","author":"Su","year":"2018","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.clim.2019.04.009_bb2175","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.autrev.2011.10.005","article-title":"In Sjogren's syndrome, B lymphocytes induce epithelial cells of salivary glands into apoptosis through protein kinase C delta activation","volume":"11","author":"Varin","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clim.2019.04.009_bb2180","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/416865a","article-title":"Increased proliferation of B cells and auto-immunity in mice lacking protein kinase C delta","volume":"416","author":"Miyamoto","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.clim.2019.04.009_bb2185","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1182\/blood-2007-08-108050","article-title":"CD28 provides T-cell costimulation and enhances PI3K activity at the immune synapse independently of its capacity to interact with the p85\/p110 heterodimer","volume":"111","author":"Garcon","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clim.2019.04.009_bb2190","doi-asserted-by":"crossref","first-page":"5969","DOI":"10.1128\/MCB.19.9.5969","article-title":"Impaired immune responses and B-cell proliferation in mice lacking the Id3 gene","volume":"19","author":"Pan","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.clim.2019.04.009_bb2195","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1126\/science.8009221","article-title":"Functional role of type I and type II interferons in antiviral defense","volume":"264","author":"Muller","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.clim.2019.04.009_bb2200","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.4049\/jimmunol.1502638","article-title":"Chronic Type I IFN Is sufficient to promote immunosuppression through accumulation of myeloid-derived suppressor cells","volume":"198","author":"Taleb","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb2205","first-page":"12","article-title":"The time is now for Sjogren\u2019s","volume":"34","author":"Trocchio","year":"2016","journal-title":"Moisture Seekers"},{"key":"10.1016\/j.clim.2019.04.009_bb2210","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0161-6420(03)00462-7","article-title":"Utility assessment among patients with dry eye disease","volume":"110","author":"Schiffman","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clim.2019.04.009_bb2215","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1542-0124(12)70043-5","article-title":"Utility assessment to measure the impact of dry eye disease","volume":"4","author":"Buchholz","year":"2006","journal-title":"Ocul Surf"},{"key":"10.1016\/j.clim.2019.04.009_bb2220","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.clim.2017.04.005","article-title":"Sjogren's syndrome: Clinical aspects","volume":"182","author":"Vivino","year":"2017","journal-title":"Clin Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb2225","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1136\/bmj.1.5120.466","article-title":"Sjogren's syndrome and systemic lupus erythematosus","volume":"1","author":"Heaton","year":"1959","journal-title":"Br Med J"},{"key":"10.1016\/j.clim.2019.04.009_bb2230","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1182\/blood-2007-10-119974","article-title":"Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph consortium","volume":"111","author":"Smedby","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clim.2019.04.009_bb2235","first-page":"63","article-title":"Functional disability and end organ damage in patients with systemic lupus erythematosus (SLE), SLE and Sjogren's syndrome (SS), and primary SS","volume":"25","author":"Sutcliffe","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb2240","first-page":"597","article-title":"Psychological well-being in patients with primary Sjogren's syndrome","volume":"18","author":"Valtysdottir","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb2245","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/030097400750001761","article-title":"Health-related quality of life in primary Sjogren's syndrome, rheumatoid arthritis and fibromyalgia compared to normal population data using SF-36","volume":"29","author":"Strombeck","year":"2000","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb2250","doi-asserted-by":"crossref","first-page":"291","DOI":"10.14219\/jada.archive.2008.0158","article-title":"Salivary dysfunction and quality of life in Sjogren syndrome: a critical oral-systemic connection","volume":"139","author":"Stewart","year":"2008","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.clim.2019.04.009_bb2255","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/rheumatology\/kep141","article-title":"Health-related quality of life, employment and disability in patients with Sjogren's syndrome","volume":"48","author":"Meijer","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.clim.2019.04.009_bb2260","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1093\/rheumatology\/kep249","article-title":"Impact of primary Sjogren's syndrome on smell and taste: effect on quality of life","volume":"48","author":"Kamel","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.clim.2019.04.009_bb2265","first-page":"351","article-title":"Influence of clinical and immunological parameters on the health-related quality of life of patients with primary Sjogren's syndrome","volume":"23","author":"Belenguer","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb2270","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/rheumatology\/ker208","article-title":"Fatigue and depression predict physician visits and work disability in women with primary Sjogren's syndrome: results from a cohort study","volume":"51","author":"Westhoff","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.clim.2019.04.009_bb2275","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/rheumatology\/kel155","article-title":"Direct healthcare costs and predictors of costs in patients with primary Sjogren's syndrome","volume":"46","author":"Callaghan","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.clim.2019.04.009_bb2280","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.14219\/jada.archive.2008.0101","article-title":"Oral involvement in primary Sjogren syndrome","volume":"139","author":"Fox","year":"2008","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.clim.2019.04.009_bb2285","first-page":"1","article-title":"SSF Members take action on Social Security disability","volume":"21","author":"Hammitt","year":"2003","journal-title":"Moisture Seekers"},{"key":"10.1016\/j.clim.2019.04.009_bb2290","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/03009748909095399","article-title":"Fibromyalgia features in patients with primary Sjogren's syndrome. Evidence of a relationship with psychological depression","volume":"18","author":"Vitali","year":"1989","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb2295","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.2147\/OPTH.S89700","article-title":"Associations between signs and symptoms of dry eye disease: a systematic review","volume":"9","author":"Bartlett","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.clim.2019.04.009_bb2300","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/aos.12012","article-title":"Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications","volume":"92","author":"Sullivan","year":"2014","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.clim.2019.04.009_bb2305","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ophtha.2014.07.026","article-title":"Ocular and systemic morbidity in a longitudinal cohort of Sjogren's syndrome","volume":"122","author":"Akpek","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clim.2019.04.009_bb2310","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S1542-0124(12)70310-5","article-title":"Extending the duration of tear film protection in dry eye syndrome: review and retrospective case series study of the hydroxypropyl cellulose ophthalmic insert","volume":"7","author":"Wander","year":"2009","journal-title":"Ocul Surf"},{"key":"10.1016\/j.clim.2019.04.009_bb2315","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0161-6420(99)90171-9","article-title":"Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren syndrome","volume":"106","author":"Marsh","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clim.2019.04.009_bb2320","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1089\/jop.2006.0091","article-title":"Recurrence after topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren's syndrome","volume":"23","author":"Hong","year":"2007","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.clim.2019.04.009_bb2325","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.2174\/0929867033457160","article-title":"Cyclophilin D as a drug target","volume":"10","author":"Waldmeier","year":"2003","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.clim.2019.04.009_bb2330","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0162-3109(00)00192-2","article-title":"Mechanisms of action of cyclosporine","volume":"47","author":"Matsuda","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.clim.2019.04.009_bb2335","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1089\/jop.2010.0085","article-title":"Topical loteprednol pretreatment reduces cyclosporine stinging in chronic dry eye disease","volume":"27","author":"Sheppard","year":"2011","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.clim.2019.04.009_bb2340","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2147\/OPTH.S126668","article-title":"Dry eye syndrome: developments and lifitegrast in perspective","volume":"12","author":"Lollett","year":"2018","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.clim.2019.04.009_bb2345","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ajo.2004.02.010","article-title":"Therapeutic effect of cevimeline on dry eye in patients with Sjogren's syndrome: a randomized, double-blind clinical study","volume":"138","author":"Ono","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clim.2019.04.009_bb2350","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archinte.159.2.174","article-title":"Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjogren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group","volume":"159","author":"Vivino","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clim.2019.04.009_bb2355","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1136\/ard.2002.003889","article-title":"Oral pilocarpine for the treatment of ocular symptoms in patients with Sjogren's syndrome: a randomised 12 week controlled study","volume":"62","author":"Tsifetaki","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clim.2019.04.009_bb2360","first-page":"691","article-title":"n-3 Fatty Acid Supplementation and Dry Eye Disease","volume":"379","author":"Maguire","year":"2018","journal-title":"New Eng J Med"},{"key":"10.1016\/j.clim.2019.04.009_bb2365","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0002-9394(00)00620-6","article-title":"Efficacy and tolerability outcomes after punctal occlusion with silicone plugs in dry eye syndrome","volume":"131","author":"Balaram","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clim.2019.04.009_bb2370","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/bjo.83.4.390","article-title":"Treatment of dry eye by autologous serum application in Sjogren's syndrome","volume":"83","author":"Tsubota","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clim.2019.04.009_bb2375","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ajo.2004.08.040","article-title":"The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study","volume":"139","author":"Kojima","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clim.2019.04.009_bb2380","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S1542-0124(12)70051-4","article-title":"Therapeutic and ocular surface indications for scleral contact lenses","volume":"5","author":"Pullum","year":"2007","journal-title":"Ocul Surf"},{"key":"10.1016\/j.clim.2019.04.009_bb2385","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/jgs.15151","article-title":"Medications that cause dry mouth as an adverse effect in older people: A systematic review and metaanalysis","volume":"66","author":"Tan","year":"2018","journal-title":"Am J Geratr Soc"},{"key":"10.1016\/j.clim.2019.04.009_bb2390","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4236\/jct.2018.93023","article-title":"Supersaturated calcium phosphate rinse vs. Standard of Care for Mitigating Mucositis in Head and Neck Chemoradiation","volume":"9","author":"Justin Brock","year":"2018","journal-title":"J Cancer Ther"},{"key":"10.1016\/j.clim.2019.04.009_bb2395","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.oooo.2014.06.015","article-title":"A phase II clinical trial of a natural formulation containing tea catechins for xerostomia","volume":"118","author":"De Rossi","year":"2014","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.clim.2019.04.009_bb2400","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/sj.bdj.4810022","article-title":"Xylitol and caries prevention--is it a magic bullet?","volume":"194","author":"Maguire","year":"2003","journal-title":"Br Dent J"},{"key":"10.1016\/j.clim.2019.04.009_bb2405","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/01.rhu.0000135553.08057.21","article-title":"Successful treatment of dry mouth and dry eye symptoms in Sjogren's syndrome patients with oral pilocarpine: a randomized, placebo-controlled, dose-adjustment study","volume":"10","author":"Papas","year":"2004","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb2410","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/art.510","article-title":"A double-blind, randomized, placebo-controlled study of cevimeline in Sjogren's syndrome patients with xerostomia and keratoconjunctivitis sicca","volume":"46","author":"Petrone","year":"2002","journal-title":"Arthritis and rheumatism"},{"key":"10.1016\/j.clim.2019.04.009_bb2415","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1001\/archinte.162.11.1293","article-title":"Cevimeline for the treatment of xerostomia in patients with Sjogren syndrome: a randomized trial","volume":"162","author":"Fife","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clim.2019.04.009_bb2420","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF00300975","article-title":"The clinical effects of electrostimulation on salivary function of Sjogren's syndrome patients. A placebo controlled study","volume":"12","author":"Talal","year":"1992","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.clim.2019.04.009_bb2425","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/art.27766","article-title":"Efficacy and safety of an intraoral electrostimulation device for xerostomia relief: a multicenter, randomized trial","volume":"63","author":"Strietzel","year":"2011","journal-title":"Arthritis Rheumatism"},{"key":"10.1016\/j.clim.2019.04.009_bb2430","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1177\/00220345940730030901","article-title":"Pilocarpine alters caries development in partially-desalivated rats","volume":"73","author":"O'Connell","year":"1994","journal-title":"J Dent Res"},{"key":"10.1016\/j.clim.2019.04.009_bb2435","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000261253","article-title":"Reversal of fissure caries in the albino rat by stimulating salivary flow with pilocarpine","volume":"24","author":"Leach","year":"1990","journal-title":"Caries Res"},{"key":"10.1016\/j.clim.2019.04.009_bb2440","first-page":"906","article-title":"Oral manifestations in patients with Sjogren's syndrome","volume":"25","author":"Soto-Rojas","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb2445","first-page":"705","article-title":"Candida albicans levels in patients with Sjogren's syndrome before and after long-term use of pilocarpine hydrochloride: a pilot study","volume":"29","author":"Rhodus","year":"1998","journal-title":"Quintessence Int"},{"key":"10.1016\/j.clim.2019.04.009_bb2450","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.joms.2013.06.214","article-title":"Antibiotic concentrations in saliva: a systematic review of the literature, with clinical implications for the treatment of sialadenitis","volume":"72","author":"Troeltzsch","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.clim.2019.04.009_bb2455","series-title":"Clinician\u2019s Guide: Salivary Gland and CHemosensory DIsroders","author":"Vivino","year":"2009"},{"key":"10.1016\/j.clim.2019.04.009_bb2460","series-title":"New Treatment Guidelines for Sjogren's Diseasee","first-page":"531","volume":"42","author":"Vivino","year":"2016"},{"key":"10.1016\/j.clim.2019.04.009_bb2465","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1093\/rheumatology\/keg289","article-title":"Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise","volume":"42","author":"Tench","year":"2003","journal-title":"Rheumatology"},{"key":"10.1016\/j.clim.2019.04.009_bb2470","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/rheumatology\/28.6.500","article-title":"Effects of aerobic conditioning in lupus fatigue: a pilot study","volume":"28","author":"Robb-Nicholson","year":"1989","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb2475","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/art.21605","article-title":"Effects of supervised cardiovascular training program on exercise tolerance, aerobic capacity, and quality of life in patients with systemic lupus erythematosus","volume":"53","author":"Carvalho","year":"2005","journal-title":"Arthritis Rheumatism"},{"key":"10.1016\/j.clim.2019.04.009_bb2480","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/(SICI)1098-240X(199706)20:3<195::AID-NUR3>3.0.CO;2-D","article-title":"Effects of exercise on fatigue, aerobic fitness, and disease activity measures in persons with rheumatoid arthritis","volume":"20","author":"Neuberger","year":"1997","journal-title":"Res Nurs Health"},{"key":"10.1016\/j.clim.2019.04.009_bb2485","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1365-2648.2006.04054.x","article-title":"Effectiveness of non-pharmacological interventions for fatigue in adults with multiple sclerosis, rheumatoid arthritis, or systemic lupus erythematosus: a systematic review","volume":"56","author":"Neill","year":"2006","journal-title":"J Adv Nurs"},{"key":"10.1016\/j.clim.2019.04.009_bb2490","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/rheumatology\/kem004","article-title":"Effects of exercise on aerobic capacity and fatigue in women with primary Sjogren's syndrome","volume":"46","author":"Strombeck","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.clim.2019.04.009_bb2495","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/03009740701867323","article-title":"Sjogren's syndrome - not just Sicca: renal involvement in Sjogren's syndrome","volume":"37","author":"Kaufman","year":"2008","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb2500","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/RHU.0000000000000595","article-title":"Tubulointerstitial nephritis in Sjogren syndrome treated with mycophenolate mofetil","volume":"23","author":"Koratala","year":"2017","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb2505","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1136\/ard.59.9.709","article-title":"Ten year follow up of pulmonary function in patients with primary Sjogren's syndrome","volume":"59","author":"Davidson","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clim.2019.04.009_bb2510","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1378\/chest.130.5.1489","article-title":"Interstitial lung disease in primary Sjogren syndrome","volume":"130","author":"Parambil","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.clim.2019.04.009_bb2515","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073774","article-title":"Prognostic factors in interstitial lung disease associated with primary Sjogren\u2019s syndrome: a retrospective analysis of 33 pathologically proven cases","volume":"8","author":"Enomoto","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.clim.2019.04.009_bb2520","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1164\/ajrccm.154.3.8810621","article-title":"Interstitial lung disease in primary Sjogren's syndrome. Clinical-pathological evaluation and response to treatment","volume":"154","author":"Deheinzelin","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clim.2019.04.009_bb2525","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3899\/jrheum.121043","article-title":"Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease","volume":"40","author":"Fischer","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb2530","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1136\/annrheumdis-2012-202293","article-title":"Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry","volume":"72","author":"Gottenberg","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clim.2019.04.009_bb2535","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1159\/000214841","article-title":"Pulmonary manifestations of Sjogren's syndrome","volume":"78","author":"Shi","year":"2009","journal-title":"Respiration"},{"key":"10.1016\/j.clim.2019.04.009_bb2540","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pain.2007.08.033","article-title":"Pharmacologic management of neuropathic pain: evidence-based recommendations","volume":"132","author":"Dworkin","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.clim.2019.04.009_bb2545","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3109\/s10165-009-0180-2","article-title":"Extreme efficacy of intravenous immunoglobulin therapy for severe burning pain in a patient with small fiber neuropathy associated with primary Sjogren's syndrome","volume":"19","author":"Wakasugi","year":"2009","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb2550","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jns.2008.12.018","article-title":"Intravenous immunoglobulin treatment for painful sensory neuropathy associated with Sjogren's syndrome","volume":"279","author":"Morozumi","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.clim.2019.04.009_bb2555","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/acr.20495","article-title":"Experience of intravenous immunoglobulin therapy in neuropathy associated with primary Sjogren's syndrome: a national multicentric retrospective study","volume":"63","author":"Rist","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.clim.2019.04.009_bb2560","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1212\/01.WNL.0000046680.47883.7D","article-title":"Benefit of IVIG for long-standing ataxic sensory neuronopathy with Sjogren's syndrome. IV immunoglobulin","volume":"60","author":"Takahashi","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.clim.2019.04.009_bb2565","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/annrheumdis-2011-200086","article-title":"Efficacy of rituximab in primary Sjogren's syndrome with peripheral nervous system involvement: results from the AIR registry","volume":"71","author":"Mekinian","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clim.2019.04.009_bb2570","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/jamaneurol.2013.3071","article-title":"A 5-year follow-up of rituximab treatment in patients with neuromyelitis optica spectrum disorder","volume":"70","author":"Kim","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.clim.2019.04.009_bb2575","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1001\/archneurol.2010.203","article-title":"Neuromyelitis optica treatment: analysis of 36 patients","volume":"67","author":"Bichuetti","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.clim.2019.04.009_bb2580","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1001\/archneurol.2009.175","article-title":"Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients","volume":"66","author":"Jacob","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.clim.2019.04.009_bb2585","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3346\/jkms.2014.29.1.12","article-title":"Evidence-based, non-pharmacological treatment guideline for depression in Korea","volume":"29","author":"Park","year":"2014","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.clim.2019.04.009_bb2590","series-title":"National Clinical Practice Guideline 90","article-title":"The treatment and managment of depression in adults","author":"Health","year":"2010"},{"key":"10.1016\/j.clim.2019.04.009_bb2595","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1176\/appi.ajp.2007.07060906","article-title":"A meta-analysis of cognitive remediation in schizophrenia","volume":"164","author":"McGurk","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clim.2019.04.009_bb2600","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.apmr.2005.03.024","article-title":"Evidence-based cognitive rehabilitation: updated review of the literature from 1998 through 2002","volume":"86","author":"Cicerone","year":"2005","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.clim.2019.04.009_bb2605","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0001-2092(06)61255-6","article-title":"Sjogren's syndrome--implications for perioperative practice","volume":"77","author":"Petruzzi","year":"2003","journal-title":"AORN J"},{"key":"10.1016\/j.clim.2019.04.009_bb2610","series-title":"Sjogren\u2019s Syndrome: A Clinical Handbook","article-title":"Perioperati3ve Management of Patients with Sjogren\u2019s Syndrome","author":"George","year":"2019"},{"key":"10.1016\/j.clim.2019.04.009_bb2615","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/acr.23209","article-title":"Perioperative timing of infliximab and the risk of serious infection after elective hip and knee arthroplasty","volume":"69","author":"George","year":"2017","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.clim.2019.04.009_bb2620","doi-asserted-by":"crossref","first-page":"R195","DOI":"10.1186\/ar4385","article-title":"Rheumatoid arthritis patients are not at increased risk for 30-day cardiovascular events, infections, or mortality after total joint arthroplasty","volume":"15","author":"Michaud","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.clim.2019.04.009_bb2625","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2174\/1874312920131210005","article-title":"Risk factors for infection following total joint arthroplasty in rheumatoid arthritis","volume":"7","author":"Somayaji","year":"2013","journal-title":"Open Rheumatol J"},{"key":"10.1016\/j.clim.2019.04.009_bb2630","doi-asserted-by":"crossref","first-page":"R145","DOI":"10.1186\/ar3087","article-title":"Risk factors for total joint arthroplasty infection in patients receiving tumor necrosis factor alpha-blockers: a case-control study","volume":"12","author":"Gilson","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.clim.2019.04.009_bb2635","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/art.40149","article-title":"American College of Rheumatology\/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty","volume":"69","author":"Goodman","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb2640","first-page":"370","article-title":"Sjogren's syndrome and metabolic disorders","volume":"81","author":"Ambrus","year":"2015","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb2645","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nri.2017.99","article-title":"The spectrum of T cell metabolism in health and disease","volume":"18","author":"Bantug","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb2650","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1089\/ars.2013.5702","article-title":"Increased mitochondrial electron transport chain activity at Complex I is regulated by N-acetylcysteine in lymphocytes of patients with systemic lupus erythematosus","volume":"21","author":"Doherty","year":"2014","journal-title":"Antioxidants Redox Signaling"},{"key":"10.1016\/j.clim.2019.04.009_bb2655","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00296-013-2850-9","article-title":"A possible genetic association with chronic fatigue in primary Sjogren's syndrome: a candidate gene study","volume":"34","author":"Norheim","year":"2014","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.clim.2019.04.009_bb2660","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1002\/art.40223","article-title":"Metabolic control of immune system activation in rheumatic diseases","volume":"69","author":"Perl","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb2665","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000098211","article-title":"Possible involvement of oxidative stress in salivary gland of patients with Sjogren's syndrome","volume":"73","author":"Ryo","year":"2006","journal-title":"Pathobiology"},{"key":"10.1016\/j.clim.2019.04.009_bb2670","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.immuni.2006.08.010","article-title":"Type I interferon in systemic lupus erythematosus and other autoimmune diseases","volume":"25","author":"Banchereau","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2019.04.009_bb2675","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/rheumatology\/kex490","article-title":"Systemic interferon type I and type II signatures in primary Sjogren's syndrome reveal differences in biological disease activity","volume":"57","author":"Bodewes","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.clim.2019.04.009_bb2680","first-page":"367","article-title":"Interferon alpha-2 (IFN alpha 2) increases lacrimal and salivary function in Sjogren's syndrome patients. Preliminary results of an open pilot trial versus OH-chloroquine","volume":"14","author":"Ferraccioli","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb2685","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/annrheumdis-2014-206090","article-title":"A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-alpha) in patients with systemic lupus erythematosus (ROSE)","volume":"75","author":"Kalunian","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clim.2019.04.009_bb2690","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1136\/annrheumdis-2015-208562","article-title":"Sifalimumab, an anti-interferon-alpha monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study","volume":"75","author":"Khamashta","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clim.2019.04.009_bb2695","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2018-000284","article-title":"Anifrolumab effects on rash and arthritis: impact of the type I interferon gene signature in the phase IIb MUSE study in patients with systemic lupus erythematosus","volume":"5","author":"Merrill","year":"2018","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.clim.2019.04.009_bb2700","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1136\/ard.2009.115378","article-title":"Cytokines in Sjogren's syndrome: potential therapeutic targets","volume":"69","author":"Roescher","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clim.2019.04.009_bb2705","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-3083.2011.02583.x","article-title":"Expression of interleukin-22 in Sjogren's syndrome: significant correlation with disease parameters","volume":"74","author":"Lavoie","year":"2011","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb2710","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nrrheum.2014.225","article-title":"A pathogenetic role for IL-21 in primary Sjogren syndrome","volume":"11","author":"Kwok","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb2715","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1093\/rheumatology\/ker448","article-title":"IL-7 drives Th1 and Th17 cytokine production in patients with primary SS despite an increase in CD4 T cells lacking the IL-7R alpha","volume":"51","author":"Bikker","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.clim.2019.04.009_bb2720","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/labinvest.2010.164","article-title":"IL17: potential therapeutic target in Sjogren's syndrome using adenovirus-mediated gene transfer","volume":"91","author":"Nguyen","year":"2011","journal-title":"Lab Invest"},{"key":"10.1016\/j.clim.2019.04.009_bb2725","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1136\/ard.2007.077891","article-title":"Lack of efficacy of etanercept in Sjogren syndrome correlates with failed suppression of tumour necrosis factor alpha and systemic immune activation","volume":"67","author":"Moutsopoulos","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clim.2019.04.009_bb2730","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-209076","article-title":"Tocilizumab for refractory organising pneumonia associated with Sjogren's disease","volume":"2015","author":"Justet","year":"2015","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.clim.2019.04.009_bb2735","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1002\/art.27564","article-title":"Significance of B cells and B cell clonality in Sjogren's syndrome","volume":"62","author":"Youinou","year":"2010","journal-title":"Arthritis Rheumatism"},{"key":"10.1016\/j.clim.2019.04.009_bb2740","doi-asserted-by":"crossref","DOI":"10.3390\/jcm5100087","article-title":"Multiple roles for B-lymphocytes in Sjogren's syndrome","volume":"5","author":"Ambrus","year":"2016","journal-title":"J Clin Med"},{"key":"10.1016\/j.clim.2019.04.009_bb2745","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.clim.2017.05.002","article-title":"The value of rituximab treatment in primary Sjogren's syndrome","volume":"182","author":"Verstappen","year":"2017","journal-title":"Clin Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb2750","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2017-212268","article-title":"Effect of rituximab on a salivary gland ultrasound score in primary Sjogren's syndrome: results of the TRACTISS randomised double-blind multicentre substudy","volume":"77","author":"Fisher","year":"2018","journal-title":"Ann Rheumatic Dis"},{"key":"10.1016\/j.clim.2019.04.009_bb2755","first-page":"2249","article-title":"Efficacy and safety of belimumab given for 12 months in primary Sjogren's syndrome: the BELISS open-label phase II study","volume":"54","author":"De Vita","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.clim.2019.04.009_bb2760","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3899\/jrheum.121368","article-title":"Disease control and safety of belimumab plus standard therapy over 7 years in patients with systemic lupus erythematosus","volume":"41","author":"Ginzler","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clim.2019.04.009_bb2765","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s12016-007-8011-8","article-title":"T lymphocytes in Sjogren's syndrome: Contributors to and regulators of pathophysiology","volume":"32","author":"Katsifis","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb2770","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2014.02.004","article-title":"T cell epitope mimicry between Sjogren's syndrome Antigen A (SSA)\/Ro60 and oral, gut, skin and vaginal bacteria","volume":"152","author":"Szymula","year":"2014","journal-title":"Clinical Immunol"},{"key":"10.1016\/j.clim.2019.04.009_bb2775","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/243723","article-title":"T regulatory and T Helper 17 cells in primary Sjogren's syndrome: facts and perspectives","volume":"2015","author":"Alunno","year":"2015","journal-title":"Mediators Inflammation"},{"key":"10.1016\/j.clim.2019.04.009_bb2780","article-title":"Systemic treatments for alopecia areata: A systematic review","author":"Lai","year":"2018","journal-title":"Australas J Dermatol."},{"key":"10.1016\/j.clim.2019.04.009_bb2785","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.17756","article-title":"Long-term, real world, efficacy of biologics for psoriasis: a single centre's experience","author":"Mercieca","year":"2019","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.clim.2019.04.009_bb2790","article-title":"Elevated T cell levels in peripheral blood predict poor clinical response following rituximab treatment in new-onset type 1 diabetes","author":"Linsley","year":"2018","journal-title":"Genes Immunol."},{"key":"10.1016\/j.clim.2019.04.009_bb2795","doi-asserted-by":"crossref","DOI":"10.1007\/s00125-018-4808-7","article-title":"A future for CD3 antibodies in immunotherapy of type 1 diabetes","author":"Chatenoud","year":"2019","journal-title":"Diabetologia."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661619302001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661619302001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:59:01Z","timestamp":1761494341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661619302001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":559,"alternative-id":["S1521661619302001"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2019.04.009","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sjogren\u2019s syndrome: An update on disease pathogenesis, clinical manifestations and treatment","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2019.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}